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Liver disease prevalence and etiology
Liver fibrosis represents a large health burden for modern society. In 2012, 806 
deaths were reported as a consequence of liver disease in general in the Netherlands.(1) 
Furthermore, since liver fibrosis is a chronic condition, that may progress to cirrhosis, it 
also has a high morbidity, which leads to hospital admissions. This morbidity is mostly 
due to complications (i.e. portal hypertension leading to esophageal varices, hepatorenal 
syndrome) and these also markedly decrease both the patients’ quality of life as well as 
life expectancy.(2) Currently, there is no effective therapy for liver fibrosis and cirrhosis 
except for liver transplantation.
Liver fibrosis and eventually cirrhosis is most commonly caused by chronic liver 
diseases such as alcoholic liver disease and viral hepatitis B and C, but also fatty liver 
disease (non-alcoholic fatty liver disease or NAFLD and non-alcoholic steatohepatitis 
or NASH), primary sclerosing cholangitis, primary biliary cirrhosis etc. Nowadays fatty 
liver disease emerges as an common etiological factor for liver fibrosis, as the incidence 
of obesity increases. Recently, it was shown that 27% of overweight people (BMI>25) had 
NAFLD compared to 7% in the lean (BMI<25) group.(3)
Acute liver disease, for example due to acetaminophen intoxication or ischemic 
hepatitis, rapidly leads to liver failure, but when there is no chronic harmful stimulus 
liver fibrosis and cirrhosis do not develop.
Liver anatomy
The liver is composed of several liver lobes which are further subdivided into lobules, 
the functional subunits of the liver. The liver has a dual blood supply: on the one hand 
oxygen-rich blood from the hepatic artery, and on the other hand nutrient-rich blood from 
the portal vein, which originates in the mesentery of the gastrointestinal tract. The portal 
vein is most important in the blood supply to the liver, accounting for approximately 
75% of the blood flow. 
The liver lobule
A lobule is a hexagonal structure. On every corner a branch of the hepatic artery and a 
branch of the portal vein enter, and in the middle of the lobule there is a central draining 










































Figure 1. A schematic overview of a liver lobule.
A schematic overview of the portal triad consisting of the portal vein (blue), hepatic artery (red) and 
draining bile duct (green) with the draining central vein in the middle of the hexagonal structure of 
the liver lobule. Taken from cms.webstudy.com.
Both the arterial and the venous portal blood run through capillaries, called sinusoids, 
towards the central vein. (Figure 2) These sinusoids are comprised of fenestrated 
endothelial cells, allowing nutrients to leave the blood flow, passing through the space 
of Disse (the space between sinusoidal epithelium and the hepatocytes), where they 
then can be absorbed at the basolateral membrane of the hepatocytes. Metabolized 
nutrients (amino acids, glucose etc) or proteins produced by the hepatocyte also can be 
excreted to the blood from the basolateral side. On the other side of the hepatocyte, at 
the canalicular membrane, various products can be excreted by the hepatocytes, such 
as (waste) metabolites, or newly synthesized proteins or hormones and bile acids. All 
these excreted products end up in the bile canaliculus. The bile canaliculi merge into 
the common hepatic bile duct, which connects to the intestine after the ductus cysticus 
(connecting to the gallbladder) joins to form the common bile duct. 
Apart from sinusoidal endothelial cells and hepatocytes, other cells present in 
the sinusoids include the Kupffer cells and hepatic stellate cells. Kupffer cells are the 
residential macrophages of the liver. 
Hepatic stellate cells reside in the space of Disse. Portal myofibroblasts are believed to 
be located in the portal areas, along the portal vein. These two cell types will be discussed 
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Figure 2. A schematic representation of a liver sinusoid. 
Both arterial and portal venous blood flows from the portal field to the central draining vein 
through capillaries, called sinusoids. The fenestrated epithelium along these sinusoids allows ex-
change of oxygen, nutrients and waste products between the blood and the hepatocytes. The bile 
ducts are formed by the canalicular membranes of the hepatocytes, draining bile back to the portal 
field, transporting bile acids produced by the hepatocytes via the gallbladder to the intestine. Other 
cells present in the sinusoid are the liver-specific macrophages, Kupffer cells, and hepatic stellate 
cells. Taken from www.mananatomy.com 
Fibrogenesis
Upon the infliction of injury (wounding), a wound-healing response starts in order 
to contain and recover the damage. This occurs in liver disease as well, irrespective of 
the nature of the damaging stimulus. After acute liver injury, a beneficial wound-healing 
mechanism regenerates damaged hepatocytes, replacing necrotic and apoptotic cells. 
However, when the cause of injury persists, excessive scar tissue (extracellular matrix) 
is deposited and fibrosis develops. The cell types responsible for the matrix production 
and deposition are the myofibroblasts. Myofibroblasts can originate from different 
sources, of which the hepatic stellate cell is the best known. In the next paragraph these 
and other cell types contributing to extracellular matrix production will be discussed. 
Hepatic stellate cells
Hepatic stellate cells (HSCs) are the main cell type involved in extracellular matrix 
production. In a non-diseased quiescent state, they are responsible for vitamin A storage 
in phenotypically characteristic fat droplets. HSCs represent 5-8% of total liver cells, and 











































Upon liver damage, irrespective of the etiology, hepatic stellate cells will become 
activated and start to proliferate. This activation process consists of fast and drastic 
morphological and functional changes.(5) Several factors can stimulate HSC activation: 
profibrogenic factors of which TGF-β1 is believed to be the most potent, but also cytokines 
released from immune cells and damaged or dying hepatocytes. 
Activation of HSCs can be divided into an initiation and a perpetuation phase.(6) 
Initiation comprises all the events leading to a phenotypically changed hepatic stellate 
cell, the myofibroblast. Losing fat droplets is the key feature of this initiation phase. 
Whether this is a cause or a consequence of HSC activation is unknown. However, it 
is observed that when the adipogenic phenotype is maintained, there is less fibrosis.
(7,8) In this initial phase, HSCs change their metabolism from oxidative phosphorylation 
to glycolysis, although retaining large numbers of mitochondria. This is known as the 
Warburg effect, which is also commonly seen in cancer cells. It was shown that the 
accumulation of lactate was vital for transdifferentiation of quiescent HSCs to activated 
HSCs.(9)
In the perpetuation phase, the activated stellate cell is primed for the different tasks 
that it now has to fulfill as a myofibroblast: the development of scar tissue and containment 
of injured tissue. In this phase the hepatic stellate cells start to proliferate upon both 
autocrine (via platelet derived growth factor or PDGF) and paracrine stimuli. The cells 
are able to migrate to a site of injury via chemotaxis, and they produce extracellular 
matrix, most prominently collagen type I. As hepatic stellate cells are myofibroblasts 
after their conversion, they are also able to contract. This causes vasoconstriction, which 
contributes to portal hypertension. 
Stellate cells also play a large role in the inflammatory response, both as a modulator 
and as an effector. Like inflammatory cells, activated stellate cells express chemotactic 
cytokines and engage in inflammatory signaling. For example via toll-like receptor 4 
(TRL4) HSCs can be stimulated to produce monocyte-attracting protein 1 (MCP1 or 
CCl2) thereby contributing to a pro-inflammatory microenvironment.(10) Besides this 
modulating role, there are reports claiming that hepatic stellate cells have the capability 
to phagocytose apoptotic bodies. This induces a profibrogenic response as well as a 












































Another source of extracellular matrix proteins, and therefore significantly involved 
in fibrogenesis, are the portal myofibroblasts (PMFs).(14) However, their contribution 
and even their existence as a different cell type besides the HSC is heavily debated. As 
they are located around the portal tract, they are believed to participate in cholestatic 
liver disease, contributing to bile duct proliferation.(15) Several groups have compared 
HSCs and PMFs, in order to identify PMFs as a distinct cell type. Tuchweber et al. found 
differences in the expression of fibroblast markers alpha-smooth muscle actin (αSMA) 
and desmin when comparing PMFs and HSCs; PMFs were desmin-negative and αSMA-
positive, whereas HSCs were desmin- and αSMA-positive. This was confirmed in 
another study, where desmin and/or αSMA positivity and negativity were studied in 
two models of liver disease, arterial ischemia and cholestasis by BDL.(16) A proteomics 
study from 2010 observed that cytoglobin, a peroxidase important in eliminating reactive 
oxygen species, was predominantly expressed in HSCs and not in PMFs. A marker for 
PMFs was phosphorylated cofilin (p-cofilin, a regulator of stress fiber formation), which 
was absent in HSCs. This observation led to the hypothesis that PMFs are more involved 
in the production of extracellular matrix, whereas HSCs are more involved in protecting 
hepatocytes.(17) A specific marker for PMFs is not yet available, therefore it is difficult 
to show the relative contribution and importance of these distinct cell types in liver 
fibrogenesis. Culturing both PMFs and HSCs, we found a striking difference in their 
ability to proliferate. Hepatic stellate cells proliferate for about 14 days after isolation, 
whereas portal myofibroblasts are able to proliferate up until passage 8 (unpublished 
data).
As described above, HSCs and PMFs are the main contributors to extracellular 
matrix (ECM) production in fibrosis.(18,19) However, other cells may also play a role in 
this fibrosis-defining process, such as bone marrow-derived cells. However, these cells 
comprise a small population, which is only observed in experimentally-induced liver 
disease and their contribution to ECM production is unknown.(20)
Epithelial-mesenchymal transition
In literature, the involvement of epithelial-mesenchymal cell transition (EMT) in 
fibrosis is proposed. This implicates that cells from epithelial origin can transdifferentiate, 
like HSCs, into (myo)fibroblasts that belong to the mesenchymal cells. In the lung and 
kidney there is evidence for a contribution of EMT to fibrosis.(21,22). However, this is 











































In fibrosis, the extracellular matrix (ECM) is not only altered quantitatively, but also 
qualitatively.(23) There is an increase in the amount of fibrillar collagen type I and III, 
proteoglycans, fibronectin and hyaluronic acid.(24-26) Deposition of this ECM in the 
liver, especially in the sinusoidal area, will lead to a distortion of normal architecture. As 
a consequence, there is impairment of the nutrient and metabolite exchange between the 
sinusoidal area and the hepatocytes. Moreover, blood flow is impaired, which explains 
the commonly seen complication of portal hypertension in liver cirrhosis patients.
While the production of extracellular matrix is increased, the degradation of ECM 
is also inhibited by the expression of tissue inhibitor metalloproteinases (TIMPs). These 
yield a powerful profibrotic effect over counteracting metalloproteinases (MMPs), which 
normally degrade newly formed ECM.(27) TIMPs thereby protect newly-produced 
matrix even though MMPs are present in high concentrations.(28,29) Thus, the TIMP/
MMP balance is important for the progression of disease.
Reversal of fibrosis
When the balance is shifted in favor of MMPs, reversal of fibrosis can occur. 
Spontaneous resolution of fibrosis in patients has been reported.(30) In animal models 
advanced fibrosis can also be resolved spontaneously, within 4-6 weeks.(31) During this 
period the liver tissue undergoes architectural remodeling, in which the fibrotic matrix is 
degraded. Moreover, there is spontaneous apoptosis of myofibroblasts as they lose their 
survival signals in a MMP-rich microenvironment.(32,33) There might be an important 
role for macrophages in this process as well, since they can produce MMPs.(34,35) 
End stage liver cirrhosis is an irreversible disease. Extensive remodeling of the 
extracellular matrix is possible if the damaging stimulus is halted, but the large mature 
septa (consisting of collagen type I and elastin) fail to recover. These elastin-rich areas 
appear to have crosslinks mediated by transglutaminase, which are highly resistant 
to enzymatic degradation. Additionally, these mature scars contain few cells, which 
probably also results in less susceptibility to degradation.(36)
Inflammatory cells and fibrogenesis
As fibrosis is the result of an exaggerated wound healing response, inflammation plays 
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of injury: neutrophils, macrophages (both from resident and bone marrow-derived 
populations) and lymphocytes.
Neutrophils, as part of the innate immune system, are one of the first cells to arrive 
at the site of injury. A variety of molecules released from damaged cells, collectively 
called damage-associated molecular patterns (DAMPs), attract neutrophils. Examples of 
DAMPs are: deoxyribonucleic acid (DNA), both nuclear and mitochondrial, adenosine 
triphosphate (ATP), cytochrome c, heat shock protein, and hedgehog ligands.(37) 
Other molecules, both organic and inorganic can also cause sterile inflammation such 
as asbestos, urate crystals, cholesterol and amyloid B.(38) Upon sensing these DAMPs, 
neutrophils adhere in the sinusoids and migrate through the sinusoids to the site of 
injury on a chemokine gradient.(39) 
This first innate reaction is non-specific, and therefore it can quickly lead to a 
widespread inflammation with activation of other immune cells, even if the original 
tissue injury was limited. 
Previously, it was shown that upon partial depletion of neutrophils, fibrosis still 
developed in an in vivo cholestatic liver disease model.(40) This indicates that other 
inflammatory cells are more important in fibrogenesis, possibly the macrophages.
Macrophages play a crucial role in inflammation.(41) They can be subdivided into two 
populations, the resident and the infiltrating macrophages. Resident macrophages in the 
liver are called Kupffer cells and reside in the sinusoids. They are believed to patrol 
the sinusoids in order to detect any injuring stimulus or invading microorganism in an 
early phase. The Kupffer cells have been shown to recognize DAMPs and, in response, 
produce the proinflammatory interleukin 1-beta (IL-1β) and other cytokines, thereby 
attracting other cells to the site of injury, such as neutrophils.(42) In addition, Kupffer 
cells can directly phagocytose the damaging stimulus. Monocytes derived from the 
blood can invade the liver when sensing cytokines and chemokines secreted by either 
neutrophils or Kupffer cells, and then differentiate into macrophages.(43,44)
Classically, macrophages are known for their phagocytosing capacities, which mean 
that they engulf and digest cell debris, pathogens or other potentially harmful materials. 
Phagocytosis can be both pro- and antifibrotic, for example phagocytosis of dead cells 
can lead to production of profibrotic cytokines, such as TGF-β1 and platelet-derived 
growth factor (PDGF), but it also removes profibrotic stimuli produced by the dead/
dying cell itself. In addition, the inflammatory response from macrophages can be both 










































inflammation is terminated by cleaning up cellular debris. Moreover, deposition of 
extracellular matrix is controlled by macrophages through the removal of apoptotic 
myofibroblasts, and the direct elimination of excess collagen deposition. 
Since macrophages can play a dual role in the wound healing response, it has been 
hypothesized that there are different phenotypes of macrophages involved in fibrogenesis 
and the resolution of fibrosis. On the one hand there is the classic, pro-inflammatory 
phenotype also called the M1 phenotype, known for its phagocytosing capabilities. On 
the other hand there is the M2 phenotype, induced upon alternative activation, which is 
characterized by a more profibrogenic phenotype.
Therefore, it can be concluded that macrophages play a central role in fibrogenesis. 
This is further confirmed by experiments where macrophages were selectively depleted 
from the liver; Duffield et al. showed reduced fibrosis in ongoing liver injury.(45) Also in 
animals deficient in the principal macrophage chemokine CCL2-CCR2-axis, accompanied 
with a reduction of monocyte/macrophage infiltration upon chronic hepatic injury, a 
protection against fibrogenesis was shown.(46)
T lymphocytes are also involved in inflammation and can orchestrate the adaptive 
immune response via the different T-helper (Th) cell phenotypes. However, they can also 
influence the macrophage phenotype, as they can produce different sets of cytokines. 
For example, a switch from Th2 to Th1 cytokines in CCl4-induced liver injury conferred 
protection against fibrosis.(47) Also Th2 cytokines can directly stimulate fibroblasts to 
synthesize collagen.
Reactive oxygen species
Oxidative stress plays an important role in fibrogenesis and the accompanying 
inflammation. Oxidative stress is defined as the inappropriate exposure to reactive oxygen 
species (ROS) and results from the imbalance between prooxidants and antioxidants 
leading to cell damage. ROS represent a variety of species, including superoxide (O2
∙-), 
hydrogen peroxide (H2O2) and hydroxyl radicals (HO
∙).(48) Especially the hydroxyl 
radical is highly reactive, whereas superoxide and hydrogen peroxide are longer-lived. 
Hydroxyl radicals can be generated through the Haber-Weiss reaction, where superoxide 
reacts with hydrogen peroxide, or through the Fenton reaction, where hydrogen peroxide 
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Under physiological circumstances ROS are produced by endogenous sources related 
to cell metabolism as a byproduct of oxygen consumption, including mitochondria, 
cytochrome P450 metabolism and peroxisomes.
In mitochondria, oxidative phosphorylation occurs, using oxidation of oxygen to 
produce adenosine triphosphate (ATP), which is the cell’s most important energy source. 
When oxidizing oxygen, harmful intermediates like superoxides are continuously 
produced. The best understood producer of superoxide is coenzyme Q in complex III.(49) 
On average 1-2% of the oxygen used in oxidative phosphorylation results in superoxide 
production. 
Cytochrome P450 family is a large and diverse group of enzymes, important in 
catalyzing the oxidation of organic substances, such as lipids, but also xenobiotics 
(acetaminophen) and alcohol. A superoxide radical or hydrogen peroxide can arise 
during the normal catalytic cycle of these enzymes.(50) 
Peroxisomes harbor a variety of activities, most of which produce H2O2 as byproduct. 
In the liver, peroxisomes are particularly involved in synthesis of bile acids and 
breakdown of (very) long chain fatty acids through β-oxidation. The latter is especially 
important when the cell is low on glucose and has to turn to glycolysis for its energy.
Physiologically, reactive oxygen species also have a protective role in the liver. 
To combat infections, ROS are produced by immune cells through enzymes such as 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidases, myeloperoxidases 
present in neutrophils and monocytes or xanthine oxidase present in the serum.(51) 
Through these mechanisms bacteria and other pathogens can be eliminated by these 
reactive oxygen species. 
Redox regulation
Superoxides and hydrogen peroxide were long believed to be solely toxic. However, 
in the past decade, many physiological roles for these reactive oxygen species have been 
described. (52,53) This phenomenon is also called redox signaling. For example, ROS 
play a role in proteolysis, especially of misfolded proteins as these are more sensitive to 
ROS than intact proteins.(54) Another example of redox signaling is via redox sensitive 
transcription factors (such as activation protein 1 or AP1 and nuclear factor kappa B or 
NF-κB), thereby influencing gene expression.(55) In addition, ROS is known to regulate 











































Pathological actions of reactive oxygen species
In the diseased liver, increased numbers of reactive oxygen species-producing cells, 
such as inflammatory cells, are present, because of the widespread inflammation. In early 
inflammation most oxidant stress appears to be present in the vasculature with Kupffer 
cells as main source.(58,59) After several hours, when the neutrophils are extravasated 
and adhere to their target, they have a significant and long-lasting contribution to the 
production of reactive oxygen species.(60) As neutrophils adhere to their target cells, 
ROS can enter the target cells, thereby generating intracellular oxidative stress and 
inducing cell death, for example in hepatocytes.
Dying hepatocytes excrete ROS as well, especially in necrosis when the cell membrane 
is disrupted and intracellular molecules, such as superoxide and proteases, are released 
in the microenvironment. Through apoptosis, hepatocytes can also enhance oxidative 
stress. This happens indirectly via attracting inflammatory cells through DAMPs excreted 
from the apoptotic bodies. 
Hepatic stellate cells also produce reactive oxygen species, as NADPH oxidase (NOX) 
is expressed in these cells.(5)(51,61) Several NADPH oxidase isoforms have been shown 
to play a role in hepatic fibrosis, for example NOX1, NOX2 and NOX4.(62-64)
Furthermore, in alcoholic liver disease alcohol and its metabolites ethanol and 
acetaldehyde can directly generate superoxide when it is metabolized by the responsible 
CYP 450 enzyme (CYP2E1).(65) 
Exposure of cells to reactive oxygen species can lead to severe damage, causing 
protein, DNA and lipid peroxidation. Products of lipid peroxidation are aldehyde-
byproducts such as 4-hydroxy-2-nonenal (HNE) and malondialdehyde (MDA).(66) 
These products are highly detrimental because of their long half-lives, allowing them 
to diffuse to distant intra- and extracellular targets, thereby amplifying the effects of 
oxidative stress. Furthermore, lipid peroxidation products are highly chemotactic (67) 
and may be responsible for the continuation and amplification of the injury.(68)
Also organelles can be damaged by exposure to ROS, especially mitochondria. 
Mitochondrial dysfunction is therefore believed to play an important role in many 
diseases, including liver disease. Radicals can oxidize and thereby damage for example 
mitochondrial DNA (MtDNA) and several mitochondrial proteins. As a consequence the 
mitochondrial membrane is compromised, leading to a disruption of the mitochondrial 
membrane potential. This is deleterious for mitochondrial function, as the mitochondrial 
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It is believed that oxidative stress also has a direct profibrogenic effect in hepatic 
stellate cells. It was shown that superoxides generated in the xanthine/xanthine oxidase 
system can stimulate redox-sensitive intracellular signaling resulting in increased 
collagen production, as well as proliferation of stellate cells.(71-73) However, we have 
previously shown that superoxide generated by menadione and hydrogen peroxide 
increase stellate cell death and inhibit proliferation.(74)
Liver disease paradox
In chronic liver disease hepatocytes die, whereas myofibroblast-like cells flourish. One 
hypothesis to explain this contradiction is that myofibroblasts have extra survival signals, 
favoring their existence over hepatocytes. We hypothesize that it is more important to 
contain the site of injury than trying to save damaged cells, since hepatocytes are able to 
proliferate and regenerate liver tissue.
A possible explanation for this paradox is that myofibroblasts are more adapted to 
exposure to oxidative stress, which would give them an advantage to survive in an 
environment where oxidative stress is excessively present.
Antioxidants
An antioxidant is defined as any substance that, when present at low concentrations 
compared with those of an oxidizable substrate, significantly delays or prevents 
oxidation of that substrate.(48) Several cellular antioxidants exist to protect the cell from 
the aforementioned physiologically- or pathologically-produced reactive oxygen species. 
Superoxide dismutases (SODs) 
This is a family of enzymes specialized in eliminating superoxide radicals, produced 
either endogenously by mitochondria, or by exogenous stimuli. Three distinct SODs 
have been identified in mammals; Copper-zinc SOD (SOD1, or CuZnSOD), manganese 
SOD (SOD2 or MnSOD) and extracellular SOD (SOD3 or ECSOD).(75) Even though they 
are structurally unrelated and are encoded by different genes, they all elicit the same 
function, namely converting the superoxide radical to hydrogen peroxide.(76) 
CuZnSOD (SOD1) is located in the cytosol and nucleus. Basal levels of SOD1 are 










































vital for mice, as knockout mice develop normally into adulthood, although there 
are problems related to aging, for example reduced female fertility and macular 
degeneration. Overexpression of SOD1 does not alter expression of SOD2, and it can also 
not compensate for SOD2 deficiency.(77,78) A mutation in the CuZnSOD-encoding gene 
has been described in amyotrophic lateral sclerosis (ALS), a neurodegenerative disease 
affecting the motor neurons.(79)
MnSOD (SOD2) is located in the mitochondria, where most superoxides are formed. 
It comprises approximately 10-15% of the total SOD activity in most tissues.(80) It has 
a different structure and genetic organization than the other two SODs and its primary 
genetic structure is highly conserved in species. It has been shown to be essential for 
life, as knockout mice die within 2-3 weeks after birth from cardiomyopathy, metabolic 
acidosis and neurodegeneration.(81) In heterozygous MnSOD knockdown mice, there 
is a cumulative increase of oxidative DNA damage and the incidence of tumors was 
doubled in these mice, compared to wild type mice.(82) Research performed in the field 
of oncology showed that MnSOD can be considered as an important tumor suppressor 
protein.(83,84) MnSOD can act directly by reducing superoxide concentrations, but also 
indirectly through modifications in the redox state of transcription factors. Transcription 
factors known to be regulated by MnSOD are, among others, nuclear factor kappa B (NF-
κB, important in inflammation and protection against apoptosis) and activation protein 
1 (AP-1, important in proliferation). Both these transcription factors are also important in 
liver fibrosis as both AP-1 and NF-κB are induced in activated hepatic stellate cells.(85)
Extracellular SOD (SOD3) is a secretory protein, predominantly present in 
extracellular fluids and the interstitial space, and on the plasma membrane. SOD3 shows 
strong homology with SOD1, both on the genetic level as well as on protein level. Despite 
this homology, both enzymes are encoded by different genes. It is the least characterized 
of the three SODs.
Catalase
Catalase decomposes hydrogen peroxide (H2O2) to water and oxygen. It is typically 
localized in peroxisomes. During fatty acid beta-oxidation H2O2 is generated as a 
byproduct in peroxisomes as described above. Knockout mice for catalase develop 
normally and are not hypersensitive to hyperoxia-induced injury.(86) Moreover, humans 
suffering from the condition acatalasemia (lack of catalase) are phenotypically healthy, 
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Therefore other mechanisms to decompose hydrogen peroxide must be more 
important or are able to compensate when catalase is unavailable. 
Glutathione and glutathione peroxidases
Glutathione peroxidases (GPx) are a family of enzymes. They catalyze the reaction of 
glutathione (GSH) and H2O2 into water and oxidized glutathione (GSSG). Glutathione 
is highly present in almost all cells, localized in the cytosol as well as in intracellular 
organelles such as the endoplasmic reticulum, the nucleus and the mitochondria. It is 
exclusively synthesized in the cytosol in a two-step process by the rate-limiting enzyme 
γ-glutamylcysteine synthetase (γ-GCS or GCL) followed by γ-glutamyl transpeptidase 
(γ-GT).(88) Oxidized glutathione can be reduced back to GSH by the enzyme GSH 
reductase (GR), a reaction requiring NADPH. This possibility to recycle GSH makes it a 
crucial antioxidant defense mechanism for cells.
In mitochondria, GSH is mainly found in the reduced form and it represents a 
minor fraction of the total GSH pool (10-15%). Mitochondria lack catalase, and therefore 
glutathione is the most important substance in the metabolism of H2O2.(89) 
Several glutathione peroxidases participate in the metabolism of H2O2, but Gpx1 is the 
main isoform. However, Gpx4 seems to be more important in the metabolism of H2O2 
than Gpx1, since Gpx1 knock-out mice are fully viable, whereas Gpx4 knockout mice 
show embryonic lethality. Gpx4 is critical in defending the mitochondrial membrane 
against oxidative stress by reducing hydroperoxide groups on membrane-associated 
phospholipids, cholesteryl esters and lipoproteins.
Glutathione peroxidases collaborate with other peroxidase enzymes, such as 
glutaredoxin, thioredoxin and peroxiredoxin.(90)
Glutaredoxins (GRX) are small redox enzymes that use glutathione as a cofactor. 
GRX act in the antioxidant defense by reducing dehydroascorbate, peroxiredoxins, and 
methionine sulfoxide reductase.(91) 
Thioredoxins (TRX) act as antioxidants by facilitating the reduction of other proteins 
by cysteine thiol-disulfide exchange. Present in all organisms, TRXs are essential for life 
as a loss-of-function mutation of either of the two human thioredoxin genes is lethal in 
an early stage of embryogenesis. The thioredoxins are kept in the reduced state by the 
flavoenzyme thioredoxin reductase, in a NADPH-dependent reaction. Thioredoxins act 










































Peroxiredoxins (PRX) are abundantly expressed throughout the cell. However, they 
have a minor contribution in the protection against oxidative stress, because of their 
moderate catalytic efficiency compared to glutathione peroxidase and catalase. However, 
next to peroxidase activity, PRXs modulate gene expression through the interaction with 
transcription factors. In addition, they protect against apoptosis and they play a role in 
innate immunity.(93)
Heme oxygenase-1
Heme oxygenases (HO’s) are enzymes involved in heme degradation.(94) Heme is 
an indispensable cofactor in oxygen-transporting proteins (for example in hemoglobin), 
but also in enzymes involved in cellular respiration (cytochrome c) or drug metabolism 
(cytochrome P450 family).(95) To date two isoforms are known, HO-1 and HO-2. HO-1 is 
known as a stress-inducible protein in almost all cells (also known as heat shock protein 
32 or Hsp32) whereas HO-2 is constitutively expressed.(96) There was a third isoform 
described, HO-3, however, this was recently shown to be a pseudogene derived from an 
HO-2 transcript.(97)
HO-1 is not a classical antioxidant, directly converting reactive oxygen species to less 
harmful molecules. However, it confers protection in multiple situations where oxidative 
stress is involved: e.g. in ischemic heart disease (98) and in the protection of transplanted 
organs via ischemic preconditioning (99-101). We have previously shown a protective 
effect of HO-1 against superoxide anion-induced apoptosis of hepatocytes.(102) 
Protection via HO-1 is most likely conveyed through the antioxidant properties of 
its products: carbon monoxide (CO), biliverdin and free iron.(103) CO modulates many 
physiological processes, among others through its anti-inflammatory and anti-apoptotic 
effects. Biliverdin is converted into bilirubin, and this is able to scavenge hydroxyl 
radicals, singlet oxygen and superoxide anions.(44) Free iron stimulates expression of 
ferritin, an iron-storage protein known to have anti-oxidative properties.(104)
Natural antioxidants 
Natural antioxidants such as vitamins or extracts of plants and herbs in fashion. 
Included in the diet or used in traditional medicine, natural products are trusted by the 
general public. This provides a “hot” debate and research climate, trying to find evidence 
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Vitamin E, or α-tocopherol, is known to reduce lipid peroxidation products during 
oxidative stress by scavenging free radicals.(105) It was shown to be protective in 
several in vivo models of liver disease, such as CCl4-induced liver damage(106), bile duct 
ligation(107) and alcoholic liver disease(108). In all these studies, vitamin C was also 
studied, and was shown to be equally protective.
Vitamin C, or ascorbic acid, can reduce products of lipid peroxidation, and was also 
found to protect neutrophils from intracellularly produced reactive oxygen species (to 
combat microorganisms). Moreover, ascorbic acid was found to interact with hypoxia-
inducible factor 1 (HIF-1), a transcription factor known to regulate many cellular 
processes such as growth and apoptosis, cell migration, energy metabolism etc.(109)
The precursor of vitamin A, β-carotene, acts as a highly efficient free radical scavenger, 
thereby protecting against lipid peroxidation.(110) Besides to this antioxidant capacity, 
vitamin A also elicited interest in liver fibrosis, as activated hepatic stellate cells lose their 
retinyl droplets within 7 days. Indeed, the outdated term for stellate cells used to be 
vitamin A-storing cells. Vitamin A is also important to repress inflammation.
Despite the above mentioned studies, there is not enough evidence to date to use 
vitamins neither in a therapeutic setting nor in preventive medicine, as long as there is a 
balanced and complete diet.(111,112) 
Nowadays, many plant and herbal extracts are studied for their potential antioxidative 
properties. One of the most investigated compounds is curcumin.(113) For centuries 
curcumin has been used in traditional medicine, for a wide range of diseases, including 
liver disease. Many in vitro studies showed anti-inflammatory and antioxidative effects 
of this compound. However, in clinical studies the evidence is limited, especially due to 
poor absorption of curcumin following oral administration.
Another widely used product, coffee, emerges as a protective agent in liver 
disease. Several epidemiological studies have shown that coffee consumption reduces 
progression of liver disease, but also is able to prevent liver disease.(114-116) As there 
are many components in coffee, it is unknown which component is responsible for the 
protective effect. It is speculated that caffeine plays an important role, as there are also 
studies showing that caffeine intake is protective.(117-119) Several in vivo animal studies, 
focusing on different models of liver disease, have confirmed these epidemiological data.











































Currently, there are no curative options for liver fibrosis or cirrhosis, apart from 
liver transplantation and/or removal of the harmful stimulus. Very effective treatment 
regimens have been developed for hepatitis B and C, achieving a sustained virologic 
response, which is correlated with decreased incidence of full-blown liver cirrhosis and 
its symptoms.(125,126) 
Anti-inflammatory agents, such as corticosteroids and immunosuppressants (i.e. 
cyclosporine A and tacrolimus), are used to inhibit progression of liver fibrosis, especially 
in auto-immune hepatitis. However, these therapies are accompanied by many side 
effects. Moreover, corticosteroids do not completely suppress progression of the disease, 
and there is no evidence for the use of immunosuppressants. 
The ideal therapy for chronic liver disease would be to target fibrogenesis, through 
specific targeting of extracellular matrix-producing myofibroblasts. Several drugs were 
tested in randomized controlled trials, for example interferon-gamma or peroxisome 
proliferator-activated receptor-gamma (PPAR-γ) agonists (thiazolidinedione). However, 
the disease progression rate was not reduced by long-term use of interferon-gamma.
(127,128) PPAR-γ agonists seemed very promising in in vitro and in vivo models, and also 
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Scope of the thesis
The aim of this thesis is to investigate the mechanism(s) of hepatic stellate cell 
activation focusing on the role of oxidative stress and anti-oxidant mechanisms, in order 
to develop a stellate cell-targeted therapy for liver fibrosis.
In chapter 2, we investigated the role of heme oxygenase-1 in cells most intimately 
involved in liver fibrogenesis, hepatic stellate cells and macrophages.
Cells can deal with reactive oxygen species by converting superoxide into hydrogen 
peroxide using superoxide dismutases. Subsequently, hydrogen peroxide can be 
converted into water and oxygen by catalase and glutathione peroxidase. In chapter 3, 
we investigated the role of antioxidant systems in the resistance of activated hepatic 
stellate cells against hydrogen peroxide-induced toxicity. In chapter 4, we studied the 
role of mitochondrial manganese superoxide dismutase (MnSOD) in hepatic stellate 
cells and we investigated the feasibility of reversing the phenotype of activated hepatic 
stellate cells to a quiescent phenotype by inducing MnSOD levels.
As caffeine seems to have antifibrotic properties, we investigated the effect of caffeine 
in vitro on hepatic stellate cells, portal myofibroblasts, macrophages and hepatocytes in 
chapter 5.
Finally, in chapter 6, the results from this thesis will be discussed, focusing on the role 
of adaptive mechanisms of hepatic stellate cells in liver fibrogenesis and how to use this 
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Background Liver fibrosis is caused by a continuous wound healing response 
accompanied by inflammation and oxidative stress. Quiescent hepatic stellate cells 
(HSCs) transdifferentiate in activated myofibroblast-like cells to produce extracellular 
matrix. Oxidative stress induces heme oxygenase-1 (HO-1), which is believed to have an 
antifibrogenic but also an immunomodulatory role. 
Aims This study aimed to investigate the cellular distribution of HO-1 during liver 
fibrogenesis in vivo and to investigate the role of HO-1 in the inflammatory and fibrotic 
response in vitro. 
Methods Bile duct ligation (BDL, 4 days to 4 weeks) was used as an in vivo model 
of liver damage; HO-1, αSMA and ED-1 expression were determined using 
immunohistochemistry. For in vitro experiments, culture-activated rat HSCs, primary rat 
Kupffer cells and the mouse macrophage cell line Raw 264.7 were used. HO-1 induction 
was achieved by infection with an adenovirus expressing HO-1 or using hemin. 
Expression of M1 and M2 type macrophage markers and HSC activation markers were 
determined using qPCR. 
Results In vivo, HO-1 expression was only localized in macrophage-like cells upon BDL. 
In cultured macrophages, HO-1 induction induced M1 type macrophage-related genes 
and reduced genes associated with M2 type macrophage. Induction of HO-1 did not 
change αSMA nor collagen type 1 mRNA expression in activated HSCs. 
Conclusions HO-1 is predominantly expressed in macrophages and an induction of 
HO-1 causes a shift to the anti-fibrotic M1 phenotype. Thus, in liver fibrogenesis HO-1 
seems to have an indirect protective effect via its immunomodulatory properties, instead 












































The incidence of chronic liver diseases evolving into liver fibrosis and cirrhosis is 
increasing worldwide. This is caused to a great extent by the increased incidence of 
obesity and accompanying liver disorders like non-alcoholic fatty liver disease (NAFLD) 
and non-alcoholic steatohepatitis (NASH) that evolve into liver fibrosis.(1,2) Liver fibrosis 
and its end stage liver cirrhosis are severe disorders with a high morbidity and mortality.
Currently, no effective drug-based treatment is available to reverse or arrest fibrosis 
and/or cirrhosis. Therefore, there is an urgent need to develop novel therapies to 
effectively treat patients with liver fibrosis. 
Liver fibrosis is characterized by increased production and deposition of extracellular 
matrix (ECM) by myofibroblast-like cells from different origins in the liver, such as the 
hepatic stellate cells (HSCs) and the portal myofibroblasts (PMFs). During fibrogenesis 
these cells transdifferentiate from a quiescent to an activated phenotype, with high 
expression of collagen type I and α-Smooth Muscle Actin (α-SMA).
The excessive production of the ECM by transdifferentiated myofibroblast-like cells 
is the result of a damaging stimulus to the liver leading to a continuous wound healing 
response. Inflammatory mediators are released by damaged cells and inflammatory cells, 
perpetuating the wound healing response. Inflammatory cells that play an important role 
in liver fibrosis are the resident macrophages, the Kupffer cells, but also macrophages 
recruited from the bone marrow. 
Most chronic liver diseases are accompanied by excessive production of reactive 
oxygen species (ROS) in the injured liver. These ROS are predominantly released in 
the inflammatory reaction. In contrast to hepatocytes, which perish in this hostile 
environment, HSCs and PMFs become activated and proliferate. This paradox may be 
explained by a resistance to ROS-induced toxicity. Indeed, it has been speculated that 
ROS may in fact promote stellate cell activation and proliferation.(3-9)
In this respect, the enzyme heme oxygenase-1 (HO-1) has elicited much interest. HO-1 
is the inducible form of the rate-limiting enzyme in heme degradation. Its products, 
carbon monoxide and biliverdin, have anti-oxidant properties.(10) HO-1 is strongly 
induced upon oxidative stress and is involved in the protection against oxidative stress-
induced damage in many organs: e.g. in ischemic heart disease (11), tubule-interstitial 
fibrosis in the kidney (12) and pulmonary fibrosis (13). In cancer, HO-1 plays an anti-










































of HO-1 is also observed in the liver and HO-1 is (in part) responsible for the phenomenon 
of ischemic preconditioning in which organs become increasingly resistant to oxidative 
stress after a prior, minor exposure to oxidative stress.(15-17) We have previously shown 
that overexpression of HO-1 in hepatocytes increases the resistance of hepatocytes to 
superoxide anion-induced apoptotic cell death.(18) In this study we also showed an 
induction of HO-1 mRNA and protein expression in a bile duct ligation model. 
HO-1 induction can retard or even reverse fibrosis in several organs, such as lung and 
kidney.(12,13) However, concerning liver fibrosis there are contradictory reports with 
regard to the antifibrotic effect of HO-1. A direct antifibrogenic effect of HO-1 has been 
proposed in human myofibroblasts isolated from human fibrotic liver explants (19,20). 
Alternatively, HO-1 is known for its immunomodulatory role, as induction of HO-1 
has been shown to be protective in multiple inflammation models.(21,22) Therefore, an 
indirect role of HO-1, modulating liver fibrosis by suppressing inflammatory responses 
in the liver, is plausible. 
The aims of this study were to investigate the cellular distribution of HO-1 in an in 
vivo model of chronic liver injury and to investigate the role of HO-1 in the liver cell types 
involved in the inflammatory and fibrotic response to chronic liver injury, the hepatic 
stellate cells and macrophages.
Materials and Methods
Animals and surgery
Specified pathogen-free male Wistar rats were purchased from Charles River 
Laboratories Inc. (Wilmington, MA, USA). Rats were housed under standard laboratory 
conditions with free access to standard laboratory chow and water. Rats were subjected 
to bile duct ligation as described previously.(23,24) Bile duct ligation was confirmed by 
determination of plasma bilirubin levels. Sham-operated animals were used as control. 
Animals were sacrificed 4 days and 1, 2 and 4 weeks after bile duct ligation. Experiments 
were approved by the local Committee for Care and Use of laboratory animals. 
Hepatic stellate cell isolation and cell culture
Hepatic stellate cells (HSCs) were isolated from male Wistar rats (500-600 g) by 
pronase (Merck, Amsterdam, the Netherlands) and collagenase-P (Roche, Almere, The 
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Norway) gradient (13% w/v) centrifugation as described previously.(25) Purity of the 
cell population was estimated at 90% after isolation, and 100% after 1 day of culturing as 
studied with auto-fluorescence. Cells were then cultured in Iscove’s Modified Dulbecco’s 
Medium with Glutamax (Invitrogen, Breda, The Netherlands) supplemented with 20% 
heat-inactivated fetal calf serum (Invitrogen), 1 mmol/L sodium-pyruvate (Invitrogen), 
1x MEM non-essential amino acids (Invitrogen), 50 µg/mL gentamycin (Invitrogen), 100 
U/mL penicillin (Lonza, Vervier, Belgium), 10 µg/mL streptomycin (Lonza), 250 ng/mL 
fungizone (Lonza) in a humidified atmosphere containing 5% CO2 at 37 °C. In order to 
study activated HSCs, the cells were seeded on plastic plates to allow culture-activation. 
Cells were passaged after 7 days and passage 1 cells were used for experiments. 
To study macrophages we used Raw 264.7 cells, a mouse macrophage cell line as 
well as primary rat Kupffer cells. Raw 264.7 cells were cultured in Dulbecco’s Modified 
Eagle Medium with Glutamax (Invitrogen, Breda, The Netherlands) supplemented with 
10% heat-inactivated fetal calf serum (Invitrogen), 50 µg/mL gentamycin (Invitrogen), 
2mmol/L L-glutamine (Invitrogen) in a humidified atmosphere containing 5% CO2 at 
37 °C. Kupffer cells were isolated from male Wistar rats (150-250 gr), using collagenase 
liver perfusion. A Percoll density cushion (25-50%) was used to separate the non-
parenchymal cell fraction as described before.(26) Kupffer cells were purified from 
the non-parenchymal cell fraction by selective adherence to tissue culture plates for 30 
min in HBSS containing Mg+ and Ca2+ supplemented with 10% FCS. After 30 min the 
supernatant was removed, and contaminating cells were washed away and Kupffer 
cells were cultured in RPMI supplemented with 10% FCS. Purity of the cell population 
was confirmed using ED1 staining. After 4h of culture, cells were used for experiments. 
Experiments and infections were performed in serum free conditions.
Overexpression of heme oxygenase-1 in stellate cells and macrophages
To induce HO-1 expression in cells, two approaches were used. A recombinant 
adenovirus containing HO-1 cDNA (AdHO-1) was used to infect HSCs (MOI 1000) 
and Raw cells (MOI 1500). A LacZ/β-gal-containing adenovirus was used as a control 
virus. The Ad5HO-1 adenovirus was a kind gift of prof. Augustine Choi, University of 
Pittsburg, Pittsburg, USA and has been described and used before.(18,27,28)
To induce HO-1 expression in macrophages a high MOI is needed in order to saturate 
scavenger receptors of these cells. This high MOI could lead to side effects and compromise 
the functionality of the Kupffer cells. Therefore we used the pharmacological agent 











































Western blot analysis of total cell lysates was performed by SDS-PAGE followed 
by semi dry-blotting to transfer the proteins to Hybond ECL nitrocellulose membrane 
(Amersham Biosciences, Piscataway, NJ, USA). Protein expression of HO-1 was detected 
using an antibody against HO-1 (OSA-111, mouse monoclonal, Stressgen Biotechnologies 
Stressgen) at a dilution of 1:500. To confirm equal loading, we used a monoclonal antibody 
against glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Calbiochem, dilution 
1:10000) or β-actin (Sigma, dilution 1:5000). The blots were analyzed in a ChemiDoc XRS 
system (Bio-Rad, Hercules, CA, USA). Protein band intensities were quantified by Image 
Lab (Bio-Rad). 
RNA isolation and quantitative real time PCR
RNA was isolated using Tri-reagent (Sigma-Aldrich) according to the manufacturer’s 
instructions. Reverse transcription was performed on 1 µg of total RNA using random 
nanomers (Sigma-Aldrich) in a final volume of 50 μL. 
Real time detection was performed on the ABI PRISM 7700 (PE Applied Biosystems) 
using the Taqman protocol. This protocol includes an initiation of 10 min at 95°C, followed 
by 40 cycles (15 seconds at 95°C, and 1 minute at 60°C). mRNA levels of 18S were used 
as an internal control. Relative gene expressions were calculated using the ΔΔCt method. 
The primers (Invitrogen) and probes (Eurogentec) used, are described in table 1.
Immunofluorescence microscopy
We performed co-staining of paraffin-embedded liver tissue for HO-1, αSMA and 
ED-1 using a sequential fluorescence method. For HO-1/αSMA staining, we performed 
antigen retrieval using microwave irradiation in citrate buffer, pH 6.0. For HO-1/ED1 
we used overnight incubation with Tris/HCl pH 9.0. The following primary antibodies 
were used: HO-1 (SPA-896, rabbit polyclonal, Stressgen Biotechnologies; dilution 1:100), 
αSMA (α-smooth muscle actin, a marker for stellate cell activation; mouse monoclonal 
antibody, Sigma Aldrich; dilution 1:1000) and ED-1 (a marker for macrophages; mouse-
anti-rat monoclonal antibody CD68, MCA 341R, Serotec; dilution 1:750). As secondary 
antibodies we used Alexa fluorophores; goat anti-rabbit Ig (Alexa Fluor 555, Invitrogen, 
1:500 diluted in PBS/1% BSA, against HO-1 expressing a red colour), goat anti-mouse 
Ig (Alexa Fluor 488, Invitrogen, 1:500 diluted in PBS/1% BSA, against α-SMA and ED-1, 
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medium S3023 (DAKO). The slides were analyzed using a confocal laser scanning 
microscope (Zeiss 410 inverted laser scan microscope). 
Statistical analysis
Results are presented as the mean of a least 3 independent experiments ±SD. A student 
t-test or a one way ANOVA test with Bonferroni as post-test was used to determine the 
significance of differences between experimental groups. A P-value of less than 0,05 
was considered statistically significant. Calculations were made using the software of 
GraphPad Prism 5.00.
Table 1 Sequences of primers and probes used for quantitative PCR analysis
Gene Primers
18S rat/mouse Sense 5’-CGG CTA CCA CAT CCA AGG A-3’
Anti-sense 5’-CCA ATT ACA GGG CCT CGA AA-3’
Probe 5’-CGC GCA AAT TAC CCA CTC CCG A -3’
αSMA rat Sense 5’-GCC AGT CGC CAT CAG GAA C-3’
Anti-sense 5’-CAC ACC AGA GCT GTG CTG TCT T-3’
Probe 5’-CTT CAC ACA TAG CTG GAG CAG CTT CTC GA-3’
Collagen type 1 rat Sense 5’-TGG TGA ACG TGG TGT ACA AGG T-3’
Anti-sense 5’-CAG TAT CAC CCT TGG CAC CAT-3’
Probe 5’-TCC TGC TGG TCC CCG AGG AAA CA-3’
COX2 mouse/rat Sense 5’-TTG TTG AGT CAT TCA CCA GAC AGA T-3’
Anti-sense 5’-GCC TTT GCC ACT GCT TGT ACA-3’
Probe 5’-CCC CAG CAA CCC GGC CAG C-3’
HO-1 rat/mouse Sense 5’-CAC AGG GTG ACA GAA GAG GCT AA-3’
Anti-sense 5’-CTG GTC TTT GTG TTC CTC TGT CAG-3’
Probe 5’-CAG CTC CTC AAA CAG CTC AAT GTT GAG C-3’
iNOS mouse Sense 5’-CTA TCT CCA TTC TAC TAC TAC CAG ATC GA-3’
Anti-sense 5’-CCT GGG CCT CAG CTT CTC AT-3’
Probe 5’-CCC TGG AAG ACC CAC ATC TGG CAG-3’
iNOS rat Sense 5’-GTG CTA ATG CGG AAG GTC ATG-3’
Anti-sense 5’-CGA CTT TCC TGT CTC AGT AGC AAA-3’
Probe 5’-CCC GCG TCA GAG CCA CAG TCC T-3’
MRC1 mouse Sense 5’-GCT ATT GGA CGC GAG GCA AT-3’
Anti-sense 5’-CGT CTG AAC TGA GAT GGC ACT TAG-3’
Probe 5’-CCA CGC AGC GCT TGT GAT CTT CA-3’
MRC1 rat Taqman assay on demand (Invitrogen)
TGFβ mouse Sense 5’-GGG CTA CCA TGC CAA CTT CTG-3’
Anti-sense 5’-GAG GGC AAG GAC CTT GCT GTA-3’
Probe 5’-CCC TGC CCC TAT ATT TGG AGC CTG GAC-3’
TGFβ rat Sense 5’-GGG CTA CCA TGC CAA CTT CTG-3’
Anti-sense 5’-GAG GGC AAG GAC CTT GCT GTA-3’
Probe 5’-CCT GCC CCT ACA TTT GGA GCC TGG A-3’
TNF-α mouse Sense 5’-GTA GCC CAC GTC GTA GCA AAC-3’
Anti-sense 5’-AGT TGG TTG TCT TTG AGA TCC ATG-3’
Probe 5’-CGC TGG CTC AGC CAC TCC AGC-3’
TNFα rat Sense 5’-GTA GCC CAC GTC GTA GCA AAC-3’












































HO-1 is expressed by macrophages after chronic liver injury
Previously, we demonstrated that HO-1 mRNA expression is increased in total rat 
liver RNA after bile duct ligation(18). To determine which hepatic cell type(s) contributes 
to the increased HO-1 mRNA expression, we performed immunofluorescence for HO-1, 
αSMA and ED1 (marker of macrophages) on liver from rats that underwent BDL surgery 
from 4 days up to 4 weeks. As shown in Figure 1A, αSMA was mainly expressed around 
vessels and in the portal areas around proliferating bile ducts, representing staining in 
myofibroblasts. HO-1 expression was localized in the parenchyma. No colocalisation of 
HO-1 and αSMA was observed at any time point after bile duct ligation.
Since the staining pattern of HO-1 resembled that of inflammatory cells, we performed 
double staining of HO-1 and ED1. As shown in Figure 1B, there is co-localisation of 
HO-1 and ED1, indicating that the most likely source of HO-1 in the liver in this model 
are macrophages, including Kupffer cells, the liver-specific macrophages. This co-
localisation is complete in early stages of BDL (after 4 days), but at later stages (after 4 
weeks of BDL) an increasing number of HO-1 negative, ED1 positive cells is observed. 
This suggests that the HO-1 expression in macrophages is transient and that it might 
have a regulatory function in the inflammatory response. 
Overexpression of HO-1 in macrophages causes a shift from M2 to M1 type macrophages
To further study a possible regulatory effect of HO-1 in macrophages, we investigated 
HO-1 expression in Raw 264.7 cells, a mouse macrophage cell line, and primary rat 
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Figure 1 HO-1 expression is predominantly localised in macrophages
(A) Immunofluorescence on liver sections of rats subjected to bile duct ligation or sham operation. 
HO-1 (red staining) is predominantly expressed intraparenchymally, α-SMA (green staining) is 
expressed around vessels and in portal areas. No co-localisation of HO-1 and α-SMA was detected. 
Magnification of 630x.
(B) Immunofluorescence on liver sections of rats subjected to bile duct ligation, or sham-operated 
rats. ED-1 (green staining) is predominantly expressed intraparenchymally, and co-localises with 
HO-1 staining (red). After 4 weeks of BDL the co-localisation is not complete, there are ED-1 positive 












































Overexpression of HO-1 in Raw cells was achieved using the adenoviral vector AdHO-1 
(Figure 2A). To induce HO-1 expression in primary Kupffer cells we used hemin, since 
functionality of Kupffer cells may be compromised by viral infection (Figure 2B).
Since HO-1 is known to be involved in inflammatory reactions and may have an 
immunomodulatory role, we investigated whether HO-1 overexpression modulated 
markers that are associated with the phenotype of macrophages. Upon HO-1 induction 
in Raw cells (Figure 2C) as well as in primary rat Kupffer cells (Figure 2D), transforming 
growth factor-β (TGFβ) and mannose receptor 1 (MRC1) mRNA levels (markers for M2 
type macrophages) decreased, whereas tumor necrosis factor-α (TNFα), cyclooxygenase-2 
(COX-2) and inducible nitric oxide synthase (iNOS) mRNA levels (markers associated 
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Figure 2 Induction of HO-1 in macrophages causes a 
shift from M2 to M1 type macrophage phenotype
A) AdHO-1 (MOI 1000, 72h) infection leads to 
significantly increased levels AdHO-1 (MOI 1000, 72h) 
infection leads to significantly increased levels of HO-1 
mRNA and protein in Raw cells compared to AdLacZ-
infected cells.
B) Hemin (10µM) induces HO-1 mRNA expression in 
primary rat Kupffer cells compared to vehicle treated 
cells.
C) TNF-α, iNOS and COX-2 mRNA levels are increased 
upon induction of HO-1 in RAW cells whereas TGF-β 
and MRC1 mRNA levels are reduced compared to 
AdLacZ infected Raw cells.
D) TNF-α, COX2 and iNOS mRNA expression is 
increased, whereas TGF-β expression is reduced upon 
induction of HO-1 expression in primary Kupffer cells. 











































Expression of α-smooth muscle actin and collagen type 1 is not modified by HO-1 overexpression 
in primary hepatic stellate cells
Since expression of HO-1 in myofibroblasts has been reported before (20) and 
since we did not observe co-staining of HO-1 and αSMA in bile duct-ligated liver, we 
examined HO-1 expression in stellate cells in more detail. The basal mRNA (data not 
shown) and protein expression (Figure 3A) of HO-1 in activated stellate cells was very 
low to absent. We next examined the effect of forced expression on stellate cell markers 
using an adenovirus overexpressing HO-1 (AdHO-1) induced HO-1 mRNA as well as 
protein levels. (Figure 3A)
Overexpression of HO-1 in activated primary rat hepatic stellate cells did not 
significantly modulate the expression of the fibrogenic markers αSMA or collagen type 
1 (Figure 3B). 
Figure 3. HO-1 overexpression in primary rat hepatic stellate cells does not influence activation
(A) AdHO-1 (MOI 1000, 72h) leads to significantly increased levels of HO-1 mRNA and protein in 
primary rat hepatic stellate cells compared to cells infected with the control virus AdLacZ.
(B) Overexpression of HO-1 did not change activation markers α-SMA and collagen type 1 












































In this study, we investigated the expression and role of heme oxygenase-1 in the in 
vivo model of cholestatic chronic liver disease: bile duct ligation. We also investigated 
the expression and role of HO-1 in vitro, focusing on the liver cell types most intimately 
involved in the inflammatory and fibrotic response: macrophages and hepatic stellate 
cells.
In the in vivo model of chronic liver disease we studied, bile duct ligation, the only 
cells expressing HO-1 are macrophages. This is most likely due to an early inflammatory 
response accompanying the acute cholestatic injury. Others have also shown an induction 
of HO-1 expression in Kupffer cells after BDL compared to sham operated rats.(29,30)
In addition, two studies reported HO-1 expression only in Kupffer cells in normal rat 
and human liver.(31-33) Our results agree with these observations; however after chronic 
liver injury we observed an increase in the number of cells expressing both HO-1 and ED-
1, as well as an increase in the intensity of expression. The increase in the number of cells 
expressing both these markers could be explained by an increased influx of macrophages 
(for example from the bone-marrow) or by an increase of a specific subpopulation of 
macrophages. In addition, it is of interest to note that the initial complete co-localisation 
of HO-1 and ED-1 after liver injury seems to disappear at later stages of the injury. 
Possibly, HO-1 has a regulatory function in the macrophages, priming them for their 
initial actions after injury, but is not necessary anymore after prolonged injury.
It is known that macrophages have dual roles in modulating progression and 
resolution of liver fibrosis (i.e. by production of TGF-β and platelet-derived growth factor 
(PDGF), matrix metalloproteinases (MMPs) and tissue inhibitor metalloproteinases 
(TIMPs), phagocytosis of debris etc.), through their ability to change their phenotype.
(34,35)
Classically, macrophages act pro-inflammatory, producing cytokines like tumor 
necrosis factor α (TNF-α), interleukin 6 (IL-6) and interleukin-1β (IL-1β), a phenotype 
known as M1 phenotype. On the other hand, macrophages can change to the M2 
phenotype, following alternative activation, producing cytokines which are more 
involved in wound remodelling (and hence fibrogenesis), such as interleukin 10 (IL-10) 
or transforming growth factor β (TGF-β). 
In this study, we show that an induction of HO-1 in macrophages caused a shift 










































a pro-inflammatory phenotype. This shift would lead to an increased inflammatory 
response, which may appear as an undesired reaction. However, we hypothesize that 
an (initial) inflammatory microenvironment is favourable over a profibrotic response, 
because it will accelerate the resolution and/or clearance of the causative agent of the 
inflammatory reaction, thereby limiting long-term activation of stellate cells and fibrosis. 
This is supported by recent reports, that showed an increased phagocytosis and bacterial 
clearance (both associated with the M1-phenotype) upon carbon monoxide-induced 
HO-1 expression.(36-38) Previously, it was reported that HO-1 is able to modulate 
the phenotype of blood and alveolar macrophages to a M2 phenotype.(39-41). This is 
contradictory to our findings of liver macrophage modulation by HO-1 induction to the 
M1 phenotype, however, this may be due to differences in organ microenvironments or 
differences between macrophage populations in different organs. 
Contrary to other studies we did not find any effect of HO-1 expression on the 
phenotype of hepatic stellate cells. The constitutive expression of HO-1 in hepatic stellate 
cells is very low to absent. Induction of HO-1 expression does not seem to have an effect 
on fibrogenic markers of stellate cells. Furthermore, upon liver damage in vivo HO-1 is 
not induced in stellate cells or other myofibroblasts. Others have demonstrated HO-1 
expression in αSMA-positive hepatic myofibroblasts in human cirrhotic liver samples.
(20) However, although these cells may resemble HSCs, they are not identical to activated 
HSCs and therefore a comparison is difficult. 
In our study, overexpression of HO-1 in activated primary hepatic rat stellate cells 
did not significantly alter the expression of the activation markers αSMA and collagen 
type 1. This is contradictory to previous studies, claiming that an antifibrogenic effect 
was established upon induction of HO-1 in hepatic stellate cells using different strategies 
(15-d-PGJ2 (20), and 2’,4’,6’-tris(methoxymethoxy) chalcone (TMMC) (42)). These 
seemingly contradictory results can be explained by the non-specific HO-1 inducers 
used by others described above. For example HO-1 induction using the PPAR-γ agonist 
15-d-PGJ2, could lead to antifibrogenic effects mediated by other PPAR-gamma targets. 
In summary, our results demonstrate that HO-1 is predominantly expressed 
by macrophages in chronic liver disease in vivo. Forced overexpression of HO-1 in 
macrophages in vitro caused a phenotypic shift in macrophages, establishing an anti-
fibrotic microenvironment. Indirectly, this possibly attenuates the activation of hepatic 












































Microscopic fluorescence imaging was performed at the UMCG Microscopy & Imaging 
Center (UMIC), which is supported by the Netherlands Organisation for Health Research 
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Background: In chronic liver disease, hepatic stellate cells (HSCs) are activated, highly 
proliferative and produce excessive amounts of extracellular matrix, leading to liver 
fibrosis. Elevated levels of toxic reactive oxygen species (ROS) produced during chronic 
liver injury have been implicated in this activation process. Therefore, activated hepatic 
stellate cells need to harbor highly effective anti-oxidants to protect against the toxic 
effects of ROS. 
Aim: To investigate the protective mechanisms of activated HSCs against ROS-induced 
toxicity.
Methods: Culture-activated rat HSCs were exposed to hydrogen peroxide. Necrosis and 
apoptosis were determined by Sytox Green or acridine orange staining, respectively. 
The hydrogen peroxide detoxifying enzymes catalase and glutathione-peroxidase (GPx) 
were inhibited using 3-amino-1,2,4-triazole (3AT) and mercaptosuccinic acid (MS), 
respectively. The anti-oxidant glutathione was depleted by L-buthionine-sulfoximine 
(BSO) and repleted with the GSH-analogue GSH-monoethylester (GSH-MEE).
Results: Upon activation, HSCs increase their cellular glutathione content and GPx 
expression, while MnSOD (both at mRNA and protein level) and catalase (at the protein 
level, but not at the mRNA level) decreased. Hydrogen peroxide did not induce cell death 
in activated HSCs. Glutathione depletion increased the sensitivity of HSCs to hydrogen 
peroxide, resulting in 35% and 75% necrotic cells at 0.2 and 1 mmol/L hydrogen peroxide, 
respectively. The sensitizing effect was abolished by GSH-MEE. Inhibition of catalase 
or GPx significantly increased hydrogen peroxide-induced apoptosis, which was not 
reversed by GSH-MEE. 
Conclusion: Activated HSCs have increased ROS-detoxifying capacity compared to 
quiescent HSCs. Glutathione levels increase during HSC activation and protect against 
ROS-induced necrosis, whereas hydrogen peroxide-detoxifying enzymes protect against 












































Oxidative stress is defined as the imbalance between pro-oxidants and anti-oxidants.
(1,2) Under normal conditions, reactive oxygen species are detoxified by various 
enzymatic and non-enzymatic antioxidants. When pro-oxidants exceed the antioxidant 
capacity of the cell, oxidative stress is the result.(1,2) Prolonged oxidative stress in the 
liver is associated with liver fibrosis and cirrhosis.(3-7) Liver fibrosis is characterized by 
the loss of hepatocytes and the activation of hepatic stellate cells (HSCs).(3-5) During 
the activation process quiescent HSCs transform into proliferating myofibroblast-like 
cells. Unlike quiescent HSCs, these activated cells lack retinoid-storing capacity, produce 
excessive amounts of connective tissue and proliferate.(4,5)
Although generation of reactive oxygen species has been implicated in the activation 
of stellate cells and liver fibrosis (6-16), little is known about the role of the different 
antioxidant systems in activated HSCs. Several enzymes are able to generate hydrogen 
peroxide, e.g. NADPH-oxidases and xanthine oxidase.(1,2) In addition, hydrogen 
peroxide is generated in the detoxification of superoxide anions by superoxide 
dismutases like the cytosolic CuZn-SOD (SOD1) and the mitochondrial Mn-SOD (SOD2).
(1,2) Pathophysiological conditions often lead to increased hydrogen peroxide levels 
produced by inflammatory cells, e.g. neutrophils.(1) Hydrogen peroxide is detoxified by 
catalase that resides in peroxisomes or by cytosolic glutathione peroxidase. Glutathione 
peroxidase converts reduced glutathione (GSH) into oxidized glutathione (GSSG).(1,2) 
To control the hydrogen peroxide level within the cell, the cell has to balance the activity 
of catalase and glutathione peroxidases relative to SODs. The aim of this study was to 




Specified pathogen-free male Wistar rats were purchased from Harlan (Zeist, the 
Netherlands). They were housed under standard laboratory conditions and had free 
access to standard laboratory chow and water. Each experiment was performed following 










































Hepatic stellate cell isolation and culture
Hepatic stellate cells (HSCs) were isolated from male Wistar rats (500-600 g) by 
pronase (Merck, Amsterdam, the Netherlands) and collagenase-P (Roche, Almere, the 
Netherlands) perfusion of the liver, followed by Nycodenz (Axis-Shield POC, Oslo, 
Norway) gradient (12% w/v) centrifugation as described previously.(17) Cells were then 
cultured in Iscove’s Modified Dulbecco’s Medium with Glutamax (Invitrogen, Breda, 
the Netherlands) supplemented with 20% heat-inactivated fetal calf serum (Invitrogen), 
1 mM sodium pyruvate (Invitrogen), 1x MEM non-essential amino acids (Invitrogen), 
50 µg/mL gentamycin (Invitrogen), 100 U/mL penicillin (Lonza, Vervier, Belgium), 10 
µg/mL streptomycin (Lonza), 250 ng/mL fungizone (Lonza) and 250 U/mL Nystatin 
(Sanofi-Synthelabo, Maassluis, the Netherlands) in a humidified atmosphere containing 
5% CO2 at 37°C. For studying activation of hepatic stellate cells, cells were seeded, grown 
to confluency and harvested at the indicated time points. Primary HSC cultures were 
passaged via trypsinization, and then cultured in Iscove’s medium with supplements as 
described above, except Nystatin. Prior to experiments, HSCs were serum-starved for 24 
hours, unless indicated otherwise. 
Experimental design
HSCs were culture-activated on tissue culture plastic for at least 7 days. The activated 
rat HSCs were exposed to oxidative stress induced by 0.2 or 1 mM hydrogen peroxide 
(Merck) or 20 or 50 µM menadione (Sigma-Aldrich, the Netherlands). The glutathione 
depleting compound L-buthionine-sulfoximine (BSO, Sigma-Aldrich, the Netherland) 
was used at 200 μM. The cell permeable glutathione donor GSH-monoethylester 
(GSH-MEE, Calbiochem, VWR, The Netherlands) was used at 5 mM. The glutathione 
peroxidase inhibitor mercaptosuccinic acid (MS, Sigma-Aldrich) was used at 10 mM 
and the catalase inhibitor 3-amino-1,2,4-triazole (3AT, Sigma-Aldrich) was used at 20 
mM. The caspase-3 inhibitor (Z-DEVD-FMK004R & D Systems, Abingdon UK) was used 
at 0.05 µM. Inhibitors were added 30 minutes prior to exposure to hydrogen peroxide, 













































Glutathione and glutathione disulfide content were determined using a 
spectrophotometry-based assay as described previously.(18,19) HSCs were harvested in 
a lysis buffer composed of 25 mM HEPES, 5 mM MgCl2, 5 mM EDTA, 2 mM PMSF, 10 
μg/μL pepstatin and 10 μg/μL leupeptin and then lysed by 3 cycles of snap-freezing 
in liquid nitrogen and thawing. Values were corrected for protein concentration, 
determined by the BioRad DC protein assay (Veenendaal, the Netherlands) according to 
the manufacturer’s instructions.
RNA isolation
RNA was isolated using Tri-reagent (Sigma-Aldrich) according to the manufacturer’s 
instructions. Reverse transcription was performed on total RNA using random nonamers 
(Sigma-Aldrich) in a final volume of 50 µl. Reverse transcription was performed in three 
steps: 10 minutes at 25°C, 1 hour at 37°C and 5 minutes at 95°C.
Quantitative Real-Time PCR
Real time detection was performed on the ABI PRISM 7700 (PE Applied Biosystems, 
the Netherlands) initialized by 10 min at 95 °C, followed by 40 cycles (15 seconds at 
95°C, and 1 minute at 60°C). Each sample was analyzed in duplicate. mRNA levels 
of 18S were used as an internal control. Reaction mixture contained qPCR mastermix 
plus-dTTP (Eurogentec, Maastricht, the Netherlands) supplemented with 900 nM sense 
and anti-sense primer and 200 nM labeled probe. The primers (Invitrogen) and probe 
(Eurogentec) used are listed in Table 1. Relative gene expressions were calculated using 
the ∆∆Ct method.
Western blot analysis
Western blot analysis was performed as described previously.(19) Equal amounts 
of protein were loaded on SDS-PAGE gels. Proteins were transferred using semi-dry 
electrophoretic transfer. Specific proteins were detected using primary antibodies: 
mouse anti-GAPDH (1:10,000, Calbiochem, VWR, the Netherlands CB1001), mouse anti-
α-smooth muscle actin (1:2,000, Sigma Aldrich), rabbit polyclonal anti-Mn-superoxide 
dismutase (1:1,000, Stressgen, Enzo life Sciences, Antwerpen, Belgium, SOD-111), 
polyclonal rabbit anti-catalase (1:2,000, Calbiochem 219010), polyclonal rabbit anti-Pex-14 










































actin (1:2000, Sigma-Aldrich A2066). Protein bands were detected using a Chemidoc XRS 
system (Bio-Rad). 
Table 1 Sequences of primers and probes used for quantitative PCR analysis
Gene Primers
18S Sense 5’-CGG CTA CCA CAT CCA AGG A-3’
Anti-sense 5’-CCA ATT ACA GGG CCT CGA AA-3’
Probe 5’-CGC GCA AAT TAC CCA CTC CCG A -3’
α-SMA Sense 5’-GCC AGT CGC CAT CAG GAA C-3’
Anti-sense 5’-CAC ACC AGA GCT GTG CTG TCT T-3’
Probe 5’-CTT CAC ACA TAG CTG GAG CAG CTT CTC GA-3’
Catalase Sense 5’-GGA TTA TGG CCT CCG AGA TCT-3’
Anti-sense 5’-ACC TTG GTC AGG TCA AAT GGA T-3’
Probe 5’-ATG CCA TCG CCA GTG GCA ATT ACC-3’
Collagen 1a1 Sense 5’-TGG TGA ACG TGG TGT ACA AGG T-3’
Anti-sense 5’-CAG TAT CAC CCT TGG CAC CAT-3’
Probe 5’-TCC TGC TGG TCC CCG AGG AAA CA-3’
CuZnSOD Sense 5’-CAG GAC CTC ATT TTA ATC CTC ACT C-3’
Anti-sense 5’-GTC TCC AAC ATG CCT CTC TTC A-3’
Probe 5’-CCG CTG GAC CGC CAT GTT TCT T-3’
GCL (γ-GCS) Sense 5’-GCC CAA TTG TTA TGG CTT TGA GT-3’
Anti-sense 5’-CCT CCC GTG TTC TAT CAT CTA CAG A-3’




HO-1 Sense 5’-CAC AGG GTG ACA GAA GAG GCT AA-3’
Anti-sense 5’-CTG GTC TTT GTG TTC CTC TGT CAG-3’
Probe 5’-CAG CTC CTC AAA CAG CTC AAT GTT GAG C-3’
MnSOD Sense 5’-CAC CGA GGA GAA GTA CCA CGA-3’
Anti-sense 5’-GAA CTT CAG TGC AGG CTG AAG A-3’
Probe 5’-CCT GAG TTG TAA CAT CTC CCT TGG CCA G-3’
TGF-β Sense 5’-GGG CTA CCA TGC CAA CTT CTG-3’
Anti-sense 5’-GAG GGC AAG GAC CTT GCT GTA-3’
Probe 5’-CCT GCC CCT ACA TTT GGA GCC TGG A-3’
Apoptosis and necrosis determination by Acridine orange and Sytox green/Hoechst 33342 nuclear 
staining.
Cells were seeded in 12-well plates and treated as indicated. Apoptosis was 
determined by assessment of nuclear condensation using Acridine orange staining 
(Sigma-Aldrich) at 2.5 µg/mL. After 6 hours, the percentage of apoptotic cells was 
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per field, amplified with 100. Percentages are the mean of two randomly chosen fields 
per condition (magnification 200 x; 15 nuclei per field).
To determine necrosis, HSCs were incubated with Sytox green nucleic acid staining 
(Invitrogen, Breda ,The Netherland) at 125 nM in combination with Hoechst 33342 
(Roche, Almere, the Netherlands) at 5 µg/mL. Sytox green penetrates cells with 
leaky plasma membranes, a hallmark of necrotic cells, but does not cross the plasma 
membranes of viable or apoptotic cells and has been validated before (19). Hoechst 33342 
crosses the plasma membrane of all cells. After 3 hours, the percentage of necrotic cells 
was determined by dividing the number of Sytox green positive nuclei by the number of 
Hoechst 33342 positive nuclei of the same field, amplified by 100. Two randomly-chosen 
fields were used to determine the average per condition (magnification 200x; 15 nuclei 
per field). Cells were monitored using an Olympus CKX41 microscope at 450-490 nm. 
Immunofluorescence microscopy
Cells were fixed with 4% paraformaldehyde, labeled and analyzed as described 
previously (20). Rabbit polyclonal antibodies against catalase (dilution 1:200; Calbiochem) 
or MnSOD (dilution 1:100, Stressgen) were use as primary antibodies, followed by 
secondary antibodies labeled with Alexa Fluor 568 or Alexa Fluor 488 (Invitrogen), 
respectively. Images were captured with a Leica TCS SP2-AOBS confocal laser scanning 
microscope (Leica, Heidelberg, Germany). 
Statistical analysis
Statistical analyses of data were performed using SPSS 14. Data are presented as 
mean ± standard deviation, unless otherwise indicated. Statistical differences between 
groups were calculated using the non-parametric Kruskal-Wallis test, followed by a 











































Glutathione peroxidase 1 expression is induced during activation of hepatic stellate cells
Marked changes in gene expression occur when quiescent HSCs transform into 
activated HSCs. Therefore, we first investigated the expression of various genes involved 
in the detoxification of reactive oxygen species during the activation process. As expected, 
alpha-smooth muscle actin (α-SMA), a marker for HSC activation, was strongly induced 
upon activation (Figure 1A). mRNA levels of catalase were significantly induced after 
two days of culture, but decreased upon complete activation of stellate cells (Figure 
1B). Manganese superoxide dismutase (Mn-SOD) mRNA levels progressively declined 
upon activation (Figure 1C), while the copper-zinc superoxide dismutase (CuZn-
SOD) expression remained unaltered (Figure 1D). Interestingly, mRNA expression of 
glutathione peroxidase 1 (GPx1) increased during activation of HSCs (Figure 1E), while 
glutamate-cysteine ligase (GCL), the rate-limiting enzyme in glutathione synthesis, was 
not altered upon HSC activation (Figure 1F). HO-1 expression in HSCs was very low and 
although a trend towards reduced heme oxygenase-1 (HO-1) expression was observed, 
this did not reach statistical significance (Figure 1G). 
The mRNA data were confirmed by analyzing the levels of the corresponding 
proteins by Western blotting (Figure 1H). Alpha-smooth muscle actin, β-actin and Gapdh 
protein expression all increased upon HSC activation. In contrast, Mn-SOD protein 
levels sharply decreased during activation of HSC. Similarly, also catalase protein levels 
dropped immediately after day 1, which was not observed for the catalase mRNA levels. 
Despite the low protein levels of catalase and MnSOD as detected by Western blotting, 
both proteins remained detectable using immunocytochemistry and revealed a typical 
peroxisomal and mitochondrial location, respectively (Figure 2). Given the large and 
unexpected difference in β-actin and Gapdh levels in quiescent versus activated HSC, 
we searched for alternative proteins to use as loading control for Western blot analysis. 
Pex14p, a protein involved in translocating proteins into peroxisomes, showed a stable 
signal relative to 18S mRNA level and total protein loaded for Western blot analysis 
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Figure 1. Expression of ROS-detoxifying enzymes during hepatic stellate cell activation
Primary rat HSC were culture-activated for 1, 3, 7 and 14 days and mRNA (A-G) and protein (H) 
levels of activation markers and anti-oxidant enzymes were quantified by RT-Q-PCR and western 
blotting, respectively. α-SMA mRNA (A) and protein (H) levels progressively increased during 
HSC activation. Catalase mRNA levels (B) transiently increased, while the corresponding protein 
rapidly declined in total cell extracts after day 1 (H). Expression of Mn-SOD progressively decreased 
during HSC activation, both at mRNA (C) and protein (H) level, while CuZn-SOD levels did not 
change (D). The expression of GPx1 increased (E), while the expression of GCL did not change (F, 
H). The expression of HO-1 was low and not significantly changed during HSC activation (G). 
Pex14p was used as loading control for Western blot analysis, since β-actin and GAPDH protein 
levels strongly increased upon HSC activation (H), The Western blots are representative of four 
independent experiments. mRNA data was corrected for 18S and is presented as means ± SD. 










































Figure 2. Catalase and Mn-SOD protein is still detectable in activated HSC.
Fully activated HSC were analyzed for the presence and subcellular location of catalase (A) and 
MnSOD (B) using immunofluorescence microscopy. A punctate staining typical for a peroxisomal 
location was observed for catalase (red stain), while MnSOD staining (green) was restricted to 
mitochondria. Magnification 630x.
Activated hepatic stellate cells have a higher glutathione content than quiescent hepatic stellate 
cells
Total glutathione levels were determined in quiescent (1 day after isolation) HSCs and 
in fully activated (>7 days after isolation) HSCs. The total cellular glutathione content 
was increased 5.6-times upon activation of HSC from 0.18 µmol/µg protein in quiescent 
HSC to 1.0 µmol/µg protein in activated HSC (Figure 3), despite unchanged GCL mRNA 
levels, the rate-limiting enzyme in the synthesis of glutathione (Figure 1). Subsequent 
analysis revealed that 88% of the total glutathione content was in the reduced (GSH) 
form (mean of 3 different isolates of HSCs).
Figure 3. Total glutathione content is increased upon hepatic stellate cell activation
Total glutathione levels were quantified in quiescent (qHSC, 1 day in culture) and fully activated 
(aHSC, > 7 days in culture) HSC. Activated HSCs have approximately 5.6-fold higher glutathione 
levels than quiescent HSCs. Results are shown as mean ± S.E.M of four independent experiments, 
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Glutathione depletion moderately increases oxidative stress in activated hepatic stellate cells
Pre-incubation of activated, serum-starved HSCs with BSO reduced total glutathione 
levels by 87% (Figure 4A). No increase was observed in either necrotic or apoptotic cell 
death (data not shown) as well as no gross changes in cellular morphology was observed 
in BSO-treated HSC. Likewise, BSO treatment also reduced glutathione content by 88% 
in activated HSCs cultured in medium containing 20% FCS (data not shown), without 
visible morphological changes.
To investigate whether glutathione depletion leads to increased oxidative stress in 
HSCs, we determined the mRNA level of the oxidative stress-responsive gene heme-
oxygenase-1 (HO-1). Depletion of glutathione increased HO-1 mRNA levels 2.3-fold 
(Figure 4B), which is only minor when compared to the induction of HO-1 by menadione 
or hydrogen peroxide (5-50 fold) (6,19). In addition, mRNA expression of GCL, the rate-
limiting enzyme in glutathione synthesis, was increased only 1.6-fold (Figure 4B). In 
contrast, glutathione depletion had no effect on the expression of the hydrogen peroxide-
detoxifying enzymes GPx1 and catalase and the superoxide dismutases Mn-SOD, and 
CuZn-SOD (Figure 4B,C). These data indicate that glutathione depletion alone only 
minimally induces markers of oxidative stress. Furthermore, glutathione depletion did 
not change the expression of the known markers of stellate cell activation α-smooth 
muscle actin (α-SMA), collagen type 1, and TGF-β (Figure 4D). Finally, glutathione 
depletion or glutathione supplementation, using GSH-MEE did not alter stellate cell 
proliferation (data not shown). Next, we analyzed whether glutathione depletion 
sensitizes HSCs for oxidative stress.
Depletion of glutathione increases sensitivity to hydrogen peroxide-induced necrosis
After depletion of glutathione with BSO, 35% and 75% of the cells became necrotic 
after a 3 hour exposure to 0.2 or 1 mM hydrogen peroxide, respectively (Figure 5). This 
indicates that glutathione depletion greatly enhanced sensitivity to hydrogen peroxide-
induced necrosis. Restoration of glutathione content, using GSH-MEE, almost completely 










































Figure 4. Glutathione depletion moderately increases oxidative stress in activated hepatic 
stellate cells 
Fully-activated HSC were treated with BSO for 20 h and analyzed for total glutathione content (A) 
and mRNA levels of anti-oxidant enzymes (B,C) and activation markers (D). Pre-treating HSCs 
with BSO depleted cellular glutathione content by 87% in serum-starved HSCs (A). BSO treatment 
moderately induced HO-1 and GCL and had no effect on GPx1 (B) nor on the expression of the anti-
oxidant enzymes catalase, Mn-SOD, and CuZn-SOD (C) or the expression of the HSC activation 
markers, α-SMA, collagen type 1 and TGF-β (D). Results are shown as mean ± st. dev. of at least 
four independent experiments, * significantly different from controls; p<0.05.
Figure 5. Glutathione depletion increases 
sensitivity of hepatic stellate cells to 
hydrogen peroxide-induced necrosis
Fully-activated HSCs were exposed for 
3 h to H2O2 in the absence or presence of 
BSO and/or GSH-MEE and analyzed for 
necrotic cell death by Sytox green nuclear 
staining. BSO treatment followed by 
exposure to 0.2 mM or 1 mM hydrogen 
peroxide (H2O2) induced necrosis in 
35% and 75% of the cells, respectively. 
Co-treatment with GSH-MEE almost 
completely prevented the induction of 
HSC necrosis by BSO+H2O2. Results 
are shown as mean ± st. dev. of four independent experiments. *Significant difference compared 
to control, p<0.05; # Significant difference compared to 0.2 mM hydrogen peroxide, p<0.05; 
•Significant difference compared to 0.2 mM hydrogen peroxide + BSO, p<0.05; †Significant 
difference compared to 1 mM hydrogen peroxide, p<0.05; ‡Significant difference compared to 1 
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Glutathione peroxidase and catalase protect against oxidative stress-induced apoptosis
The importance of the antioxidant enzyme GPx in the protection of activated HSCs 
against oxidative stress was investigated using the GPx inhibitor mercaptosuccinic acid 
(MS). Inhibition of GPx using mercaptosuccinic acid increased apoptosis in the absence of 
hydrogen peroxide and in the presence of 0.2 mM and 1 mM hydrogen peroxide (Figure 
6A). No effects on necrosis were observed under these conditions (data not shown).
The importance of the antioxidant enzyme catalase in the protection of activated 
HSCs against oxidative stress was investigated using the catalase inhibitor 3-amino-
1,2,4-triazole (3-AT). This inhibitor significantly induced apoptotic cell death (18%) in 
HSCs after 6 hours, even in the absence of exogenous hydrogen peroxide (Figure 6A). 
Cells treated with 0.2 or 1 mM hydrogen peroxide in the presence of the inhibitor catalase 
showed even higher levels of apoptosis, 22% an 44% respectively (Figure 6A). No effects 
on necrosis were detected at this time point.
To investigate the importance of the hydrogen peroxide detoxifying enzymes catalase 
and GPx in the protection against superoxide anions that are converted into hydrogen 
peroxide by superoxide dismutases, we exposed activated stellate cells to the superoxide 
anion generator menadione. As described previously, menadione at 20 µM induced 
predominantly apoptotic cell death, which was reduced by the glutathione donor GSH-
MEE.(19) Inhibition of catalase in the presence of menadione had no effect on apoptotic 
cell death (Figure 6C), but slightly increased necrotic cell death (data not shown), 
whereas inhibition of GPx did neither modulate apoptotic (Figure 6C) nor necrotic 
cell death (data not shown). Prior reduction of cellular glutathione levels by BSO did 
not aggravate apoptotic cell death induced by 20 µM menadione. Menadione at 50µM 
resulted in detachment of cells and massive necrotic cell death. (data not shown)  
Combined inhibition of glutathione peroxidase and catalase elevates apoptosis of HSCs
Inhibiting both GPx and catalase by cotreatment with MS and 3AT resulted in 22% 
apoptotic cells after 6 hours even in the absence of exogenous hydrogen peroxide (Figure 
6A). Exposing these cells to hydrogen peroxide induced apoptosis even further: to 49% 
in co-treatment with 0.2 mM hydrogen peroxide and to 62 % in co-treatment with 1 mM 
hydrogen peroxide (Figure 6A). Increasing the glutathione content using the glutathione 
donor GSH-MEE did not change the cell viability under these conditions (Figure 6B). 
Inhibition of caspase-3 partially decreased apoptosis of HSCs (Figure 6B). Necrotic cell 










































Figure 6. Inhibition of glutathione peroxidase and/or catalase induces apoptosis in activated 
hepatic stellate cells
Fully-activated HSCs were exposed for 6 h to H2O2 in the presence or absence of the catalase 
inhibitor 3-AT and/or GPx inhibitor MS (A), as well as in the presence or absence of GSH-MEE or 
the caspase-3 inhibitor Z-DEVD-FMK (B) and analyzed for apoptotic cell death by acridine orange 
staining. Values are given as percentage apoptotic nuclei. 3-AT and MS treatment alone significantly 
increased the number of apoptotic HSC, which was further enhanced by cotreatment with H2O2 
(A). Apoptosis induced by treatment with H2O2 in the presence of inhibitors of GPx and catalase is 
inhibited by a blocker of caspase-3 activity, but not by supplementing glutathione through GSH-
MEE (B). Results are shown as mean ± stdev of at least four independent experiments. *Significant 
difference compared to control, p<0.05; ^ Significant difference compared to MS, p<0.05; §Significant 
difference compared to 3AT, p<0.05; † Significant difference compared to 1 mM hydrogen peroxide, 
p<0.05; °Significant difference compared to MS + 3AT, p<0.05; #Significant difference compared 
to 0.2 mM hydrogen peroxide, p<0.05; •Significant difference compared to 0.2 mM hydrogen 
peroxide + 3-AT + MS, p<0.05; ‡Significant difference from 0.2 mmol/L hydrogen peroxide + 3-AT 
+ MS, p<0.05; ⁿSignificant difference from 1 mmol/L hydrogen peroxide + 3-AT + MS, p<0.05.
(C) Fully-activated HSCs were exposed for 9 h to 20µM menadione in the presence or absence 
of the catalase inhibitor 3-AT, the GPx inhibitor MS, as well as the glutathione depleting agent 
BSO analyzed for apoptotic cell death by acridine orange staining. Values are given as percentage 
apoptotic nuclei. Menadione induced apoptotic cell death at 20 µM. 3-AT and MS did not 
significantly modulate apoptotic cell death by menadione. Moreover, depletion of glutathione 
using BSO did not aggravate menadione-induced apoptotic cell death. Results are shown as mean 












































Chronic liver injury is almost invariably accompanied by increased oxidative stress, 
activation of stellate cells and fibrogenesis.(3-7) Activated HSCs must be well protected 
against oxidative stress, since they survive and proliferate in the chronically injured 
liver. The oxidative stress in chronically injured liver is composed of several reactive 
oxygen species, including hydrogen peroxide and superoxide anions. In this study, we 
have investigated the resistance of hepatic stellate cells to hydrogen peroxide-induced 
injury. We demonstrate that this resistance is to a large extent due to a high intracellular 
glutathione content and increased expression of glutathione peroxidase in activated 
stellate cells. Although an increased glutathione content in activated stellate cells has 
been reported before (21), the implications have never been investigated in the context of 
oxidative stress-induced cell death. 
Maher et al. showed, in addition to increased glutathione levels upon activation, an 
increase in the activity and mRNA level of glutamate-cysteine ligase (GCL), the rate-
limiting enzyme in glutathione synthesis.(21) We did not observe an induction of GCL 
mRNA upon stellate cell activation in our experiments. The increased cellular glutathione 
content is most likely due to a higher activity of GCL, especially since GCL activity is 
known to be regulated by the glutathione content.(22) It is unlikely that the increased 
glutathione content is due to reduced activity of the GSSG export pump multidrug 
resistance protein 1 (Mrp1), since we have previously shown that the expression of this 
transporter is increased in activated stellate cells and contributes significantly to the 
survival of activated stellate cells.(23)  
Upon HSC activation, the expression of the hydrogen peroxide detoxifying enzyme 
glutathione peroxidase 1 (GPx1) is increased. This increase may be an adaptive response 
to oxidative stress. Indeed, mice over-expressing GPx1 are better protected against 
oxidative stress and they survive concentrations of the oxidant paraquat that are lethal 
in wild type mice and even more harmful in GPx1 knockout mice.(24,25) Mice that 
overexpress GPx1 are also more resistant to oxidative stress due to myocardial ischemia-
reperfusion injury(26) It should be noted that glutathione is essential for the activity 
of GPx, since GPx converts reduced glutathione into oxidized glutathione. This might 
explain the coordinated increase in cellular glutathione content and GPx expression 
during the activation process of hepatic stellate cells. Therefore, our data suggest that 










































quiescent stellate cells. Interestingly, upon activation the mRNA expression level of 
the mitochondrial superoxide anion converting enzyme Mn-SOD is reduced, both at 
the mRNA and at the protein level. This finding is partially at variance with previous 
reports that revealed an initial increase in MnSOD mRNA expression, followed by a 
steady decrease of MnSOD mRNA expression.(27) Disruption of the Mn-SOD gene, a 
known tumor suppressor gene, is lethal in mice, which is a direct result of mitochondrial 
dysfunction, leading to metabolic acidosis, ketosis and accumulation of lipids in the liver 
and skeletal muscle.(28,29) Characterization of the heterozygous Mn-SOD knockout 
mice revealed no compensatory increase in other ROS-detoxifying enzymes, like 
glutathione peroxidase, CuZn-SOD or catalase.(30) Since Mn-SOD is restricted to the 
mitochondria, changes in its activity may not affect other components of the antioxidant 
defense system in other cellular compartment like the cytoplasm.(30) At present it is not 
known how the activated stellate cells detoxify the reactive oxygen species generated in 
mitochondria. One possibility is that the residual MnSOD protein content, as determined 
by Western-blotting and immunofluorescence, is sufficient to detoxify ROS generated in 
mitochondria. The reduction in Mn-SOD mRNA expression during activation could be 
due to the strong reduction of the transcription factor peroxisome proliferator-activated 
receptor-γ (PPAR-γ) that occurs during stellate cell activation. (data not shown and (31)) 
MnSOD expression is controlled by PPAR-γ: in PPAR-γ knockout mice, the expression 
of Mn-SOD is also reduced (32) and activation of PPAR-γ with the agonists rosiglitazone 
or rosuvastatin enhanced MnSOD activity and expression (33,34). 
The catalase mRNA levels transiently increased during the activation process of 
HSC, which is largely in line which observations made by De Bleser et al. who analyzed 
catalase regulation during HSC activation by Northern blot analysis.(27) However, in 
contrast to the mRNA levels, the cellular catalase protein content sharply dropped 1 
day after plating HSC. A typical peroxisomal staining of catalase remained detectable 
in fully activated HSC, indicating that some residual catalase protein was present in 
these cells. However, clearly, the catalase protein level was not an accurate reflection of 
the catalase mRNA content. At present it is unclear why the catalase protein disappears 
from activated stellate cells, but this may be a result of a rapid and selective degradation 
of this antioxidant protein. The low catalase levels did not sensitize activated HSCs to 
acute H2O2-induced necrosis, indicating the presence of an alternative H2O2 scavenging 
mechanism(s) in activated HSCs. However, blocking catalase activity by 3-AT made HSCs 
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or 1.0 mM H2O2. A similar effect was observed after blocking GPx activity, indicating that 
these 2 proteins play a key role in regulating apoptotic cell death in HSCs. 
HSCs increase their glutathione levels upon activation. However, glutathione 
depletion has no direct effect on stellate cell morphology (35) and in this study, we show 
that glutathione depletion also has no effect on the expression of markers of stellate cell 
activation, such as collagen type I, α-SMA and TGF-β or anti-oxidant genes like catalase, 
Mn-SOD, CuZn-SOD, and GPx1. The glutathione levels per se do not seem to be a key 
mechanism in developing the activated phenotype. 
Although increased mRNA levels of GCL and HO-1 were observed after glutathione 
depletion, these increases were modest, indicating that depletion of glutathione alone 
does not exert significant oxidative stress on stellate cells. Induction of GCL mRNA levels 
after glutathione depletion has also been shown in lung epithelial cells (36), endothelial 
cells (37), and in rat liver in vivo (38). Although HO-1 has been reported to inhibit HSC 
proliferation via p38 activation (39), we did not find an alteration in the proliferation 
rate of stellate cells after HO-1 induction due to glutathione depletion. Possibly, the 
induction of HO-1 by glutathione depletion in our study is too modest to have an effect 
on p38 phosphorylation and subsequent HSC proliferation. The induction of HO-1 
by glutathione depletion was only 2.3-fold, whereas Li et al showed at least a 10-fold 
induction of HO-1 expression using 15-deoxy-delta-12,14-prostaglandin J2.(39,40)
Although glutathione depletion per sé had no effect on stellate cell viability, 
glutathione depletion increased the sensitivity of the cells to hydrogen peroxide-induced 
necrosis. Replenishing glutathione reduced necrotic cell death, without a shift towards 
apoptosis. Inhibition of the hydrogen peroxide-detoxifying activity by inhibitors of 
glutathione peroxidase or catalase induced HSC apoptosis, both in the absence and in the 
presence of exogenous hydrogen peroxide. Apoptotic cell death as a result of combined 
inhibition of glutathione peroxidase and catalase was shown to be independent of 
glutathione content, but partially dependent on caspase-3 activity. The superoxide anion 
donor menadione dose-dependently induces apoptotic cell death in activated HSCs.(19) 
Inhibition of hydrogen peroxide detoxifying enzymes did not significantly modulate 
menadione-induced cell death, indicating that increased superoxide generation did not 
lead to a massive, superoxide dismutase-mediated, increase in hydrogen peroxide.
The observed difference in mode of cell death, necrosis after glutathione depletion 
and apoptosis after inhibition of hydrogen peroxide detoxifying enzymes, may be 










































cellular redox state.(41,42) Changes in the glutathione content will affect redox status 
and is known to influence activation of MAP-kinases, transcription factors and caspases.
(41-43) In the presence of glutathione, caspases that require reduced cysteine-sulfhydryl 
groups in their catalytic site, can still be activated when the enzymes GPx and catalase 
are inhibited, because this inhibition is not likely to change the redox state of the cell. In 
contrast, in the absence of glutathione, e.g. after glutathione depletion, cells exposed to 
hydrogen peroxide cannot activate caspases and the apoptotic program and cell death 
is shifted towards necrosis. Such a shift from apoptotic to necrotic cell death has been 
reported before in hepatocytes exposed to superoxide anions.(44) 
In summary, our study reveals important changes in the defense against oxidative 
stress of hepatic stellate cells during activation. These changes are characterized by 
increased cellular glutathione content and GPx1 mRNA expression. Furthermore, we 
demonstrate that both glutathione and the hydrogen peroxide-converting enzymes GPx 
and catalase are important in the resistance against hydrogen peroxide-induced cell 
death. Our data suggests that activated hepatic stellate cells in vivo may acquire increased 
resistance to necrotic cell death, while remaining sensitive to apoptosis, providing an 
explanation for their survival in the fibrotic liver and their apoptotic clearance during 
reversal of fibrosis. 
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Chapter 4
Overexpression of manganese superoxide dismutase 
reverses hepatic stellate cell activation
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Introduction: Liver fibrosis and cirrhosis are listed in the top 10 causes of death in the 
Western world. No effective therapy is available yet. Liver fibrosis is characterized by 
increased production of extracellular matrix (ECM) by hepatic stellate cells (HSCs). 
During fibrogenesis, HSCs transdifferentiate from a quiescent to a myofibroblast-like 
phenotype and produce excessive amounts of ECM. Activated HSCs have increased 
expression of Transforming Growth Factor β1 (TGF-β1), collagen type I and α-Smooth 
Muscle Actin (α-SMA). Superoxide anions, with mitochondria as a main source, have 
been implicated to promote HSC activation. Manganese superoxide dismutase (MnSOD) 
is an antioxidant enzyme in mitochondria. Previously, we found that MnSOD expression 
decreases dramatically upon HSC activation. Here, we studied the role of MnSOD in 
HSC activation. 
Methods: Human MnSOD was overexpressed in activated rat hepatic stellate cells (aHSC) 
using an adenovirus (Ad-MnSOD). Messenger RNA levels of MnSOD and the stellate 
cell activation markers α-SMA, collagen type 1, TGF-β1 and PPAR-γ, were determined 
by qPCR. Protein expression was analyzed by Western blotting and immunofluorescence 
microscopy. 
Results: Ad-MnSOD infection led to a transient increase in MnSOD expression in aHSC, 
which was accompanied by a decrease in the activation markers α-SMA (-80%), collagen 
type 1 (-70%) and TGF-β (-70%) and an increase in PPAR-γ (+ 2.4-fold), an adipogenic 
transcription factor. aHSC with increased MnSOD expression showed decreased cellular 
staining of collagen type 1 and α-SMA, of which also the typical filamentous structure 
was disturbed. 
Conclusion: These data show that overexpression of MnSOD reduces the activation of 












































Liver fibrosis and its end stage liver cirrhosis are severe disorders, with a high 
morbidity and mortality. The incidence of chronic liver diseases that progress to liver 
fibrosis and cirrhosis is increasing worldwide. To a large extent this is caused by the 
increased incidence of obesity and accompanying liver disorders like non-alcoholic fatty 
liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).(1,2) Currently, there is 
no effective drug-based treatment available to arrest or reverse fibrosis and/or cirrhosis. 
Therefore, there is an urgent need to develop novel therapies to effectively treat patients 
with liver fibrosis. 
Liver fibrosis is characterized by increased production of extracellular matrix (ECM) 
by myofibroblasts-like cells from different origins in the liver, such as the hepatic stellate 
cells (HSCs) and the portal myofibroblasts (PMFs).(3) Upon liver injury, these cells 
become activated and transdifferentiate into contractile and migratory cells that produce 
excessive amounts of extracellular matrix, in particular collagen type 1, leading to the 
formation of scar tissue. The increased expression of α-Smooth Muscle Actin (α-SMA) 
is a typical feature of hepatic myofibroblasts that supports the high contractility and 
mobility of these cells.
Most chronic liver diseases are accompanied by excessive production of reactive 
oxygen species (ROS) in the injured liver.(4,5) Whereas hepatocytes die in the presence 
of oxidative stress, hepatic stellate cells (HSCs) appear resistant to ROS-induced toxicity 
as they thrive in this harmful environment. Indeed, it has been speculated that ROS may 
in fact promote stellate cell activation and proliferation.(6-8) Several mechanisms may 
explain the resistance of HSCs to ROS-induced toxicity, including the expression of anti-
oxidant enzymes. A number of anti-oxidants are required to efficiently detoxify ROS. 
First, superoxide dismutases convert superoxide into hydrogen peroxide, which is then 
further degraded by catalase and/or glutathione peroxidase. Three forms of superoxide 
dismutases exist; mitochondrial manganese superoxide dismutase (MnSOD, SOD 
2), cytosolic copper-zinc superoxide dismutase (CuZnSOD, SOD 1) and extracellular 
dismutase (EcSOD, SOD3).(9) As mitochondrial oxidative phosphorylation is a major 
producer of ROS that may account for up to 90% of cellular ROS (10), it is believed that 
MnSOD is most important for detoxifying ROS in cells. 
Previously, it has been shown that adenoviral-overexpression of MnSOD protects the 










































ischemia-reperfusion liver disease.(11-13) In apparent contradiction, we recently found 
that MnSOD mRNA and protein levels sharply drop upon in vitro activation of hepatic 
stellate cells, while CuZnSOD levels remain unchanged.(14) It is unclear whether HSC 
differentiation is causally related to MnSOD expression, or whether this is merely a 
consequence of HSC activation.
Therefore, the aim of this study was to increase MnSOD expression in activated 
hepatic stellate cells and study its effects on the activation state and to elucidate potential 
mechanisms involved in this process. 
Methods & Materials
Cell isolations and culture conditions
Hepatic stellate cells (HSCs) were isolated from male Wistar rats (500-600 g) by 
pronase (Merck, Amsterdam, the Netherlands) and collagenase-P (Roche, Almere, The 
Netherlands) perfusion of the liver, followed by Nycodenz (Axis-Shield POC, Oslo, 
Norway) gradient (13% w/v) centrifugation as described previously.(15) Cells were then 
cultured in Iscove’s Modified Dulbecco’s Medium with Glutamax (Invitrogen, Breda, The 
Netherlands) supplemented with 20% heat-inactivated fetal calf serum (Invitrogen), 1 
mmol/L sodium-pyruvate (Invitrogen), 1x MEM non-essential amino acids (Invitrogen), 
50 µg/mL gentamycin (Invitrogen), 100 U/mL penicillin (Lonza, Vervier, Belgium), 10 
µg/mL streptomycin (Lonza), 250 ng/mL fungizone (Lonza) in a humidified atmosphere 
containing 5% CO2 at 37 °C. Primary HSC cultures were allowed to culture-activate in 7 
days, then passaged via trypsinization. The cells were used for experiments at passage 1, 
after allowing attachment in 6-wells plates. All experiments were performed in serum-
free conditions unless described otherwise.
Adenoviral constructs and infection of activated hepatic stellate cells with adenoviruses
HSCs were transfected with a recombinant adenovirus containing the human 
MnSOD cDNA (AdMnSOD). A LacZ/β-gal containing adenovirus was used as a control 
virus. The AdMnSOD adenovirus was a kind gift of prof. T. O’Brien, National University 
of Ireland, Galway, Ireland and has been described before.(16) Optimal duration and 
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RNA isolation, RT-PCR and quantitative real time PCR
RNA was isolated using Tri-reagent (Sigma-Aldrich) according to the manufacturer’s 
instructions. Reverse transcription was performed on 1µg RNA using random nanomers 
(Sigma-Aldrich) in a final volume of 50 μL. Reverse transcription was performed in three 
steps: 10 minutes at 25°C, 1 hour at 37°C and 5 minutes at 95°C. Real time detection was 
performed on the ABI PRISM 7700 (PE Applied biosystems) using the Taqman protocol. 
This protocol includes an initiation of 10 min at 95°C, followed by 40 cycles (15 seconds 
at 95°C, and 1 minute at 60°C). mRNA levels of 18S were used as an internal control. 
Each sample was analyzed in duplicate. Relative gene expressions were calculated using 
the ΔΔCt method. The primers (Invitrogen) and probes (Eurogentec) used, are described 
in Table 1. To determine human MnSOD mRNA expression produced as a consequence 
of adenoviral MnSOD infection, we used a Taqman Assay on Demand from Invitrogen, 
however we found that this also detected rat MnSOD expression.
Table 1 Sequences of primers and probes used for quantitative PCR analysis
Gene Primers
18S rat Sense 5’-CGG CTA CCA CAT CCA AGG A-3’
Anti-sense 5’-CCA ATT ACA GGG CCT CGA AA-3’
Probe 5’-CGC GCA AAT TAC CCA CTC CCG A -3’
αSMA rat Sense 5’-GCC AGT CGC CAT CAG GAA C-3’
Anti-sense 5’-CAC ACC AGA GCT GTG CTG TCT T-3’
Probe 5’-CTT CAC ACA TAG CTG GAG CAG CTT CTC GA-3’
Catalase rat Sense 5’-GGA TTA TGG CCT CCG AGA TCT-3’
Anti-sense 5’-ACC TTG GTC AGG TCA AAT GGA T-3’
Probe 5’-ATG CCA TCG CCA GTG GCA ATT ACC-3’
Collagen type 1 rat Sense 5’-TGG TGA ACG TGG TGT ACA AGG T-3’
Anti-sense 5’-CAG TAT CAC CCT TGG CAC CAT-3’
Probe 5’-TCC TGC TGG TCC CCG AGG AAA CA-3’
CuZnSOD rat Sense 5’-CAG GAC CTC ATT TTA ATC CTC ACT C-3’
Anti-sense 5’-GTC TCC AAC ATG CCT CTC TTC A-3’
Probe 5’-CCG CTG GAC CGC CAT GTT TCT T-3’
GPx1 rat Sense 5’-GGACATCAGGAGAATGGCAAGA-3’
Anti-sense 5’-CGCACTTCTCAAACAATGTAAAGTTG-3’
Probe 5’-TTCCCTCAAGTATGTCCGACCCGGTG-3’
PPAR-γ rat Sense 5’-CAC AAT GCC ATC AGG TTT GG-3’
Anti-sense 5’-GCT GGT CGA TAT CAC TGG AGA TC-3’
Probe 5’-CCA ACA GCT TCT CCT TCT CGG CCT G-3’
TGFβ rat Sense 5’-GGG CTA CCA TGC CAA CTT CTG-3’
Anti-sense 5’-GAG GGC AAG GAC CTT GCT GTA-3’











































In order to confirm the targeting of the recombinant MnSOD protein to the 
mitochondria, we incubated the cells at 37°C with MitoTracker® Red CMXROS (Life 
technologies) at an end concentration of 50 nmol/L. After allowing 30 minutes for the 
probe to enter the cells, cells were fixed using 4% paraformaldehyde/PBS and were 
processed for immunofluorescence microscopy.
Immunofluorescence microscopy
(17)Activated HSCs were cultured on glass coverslips. After adenoviral transfection, 
cells were fixed using 4% paraformaldehyde/PBS. Prior to staining, cells were 
permeabilized with 1% Triton-X100 for 5 minutes. Non-specific antibody binding sites 
were blocked for 30 min in 0.5% BSA/PBS. Subsequently, cells were incubated with 
primary antibodies (MnSOD: Stressgen, rabbit polyclonal, dilution 1:400 in 0.5% BSA/
PBS; α-SMA: Sigma, mouse monoclonal, dilution 1:500 in 0.5% BSA/PBS; collagen 
1α1: Southern Biotech, goat polyclonal, dilution 1:30 in 0.5% BSA/PBS) for 1-2 hours 
at room temperature. Alexa fluorophores (Molecular probes, diluted 1:500) were used 
as secondary antibodies. Finally, coverslips were mounted in fluorescence mounting 
medium S3023 containing DAPI for nuclear staining (DAKO). The slides were visualized 
using a Zeiss 410 inverted laser scan microscope.
Statistical analysis
All results are presented as the mean of at least three independent experiments 
using cells from different rats ± standard deviation. Statistical analysis of the results 
was performed using GraphPad Prism 5 for Windows. A student t-test or two-way 
ANOVA followed by Bonferroni’s multiple comparison tests were used to determine 
significant differences between the groups. A p-value <0.05 was considered statistically 
significant.  
Results
MnSOD expression is induced upon infection of hepatic stellate cells
First, we optimized the infection procedure for culture-activated HSC using the 
MnSOD-expressing adenovirus. Only at a high multiplicity of infection (MOI) of 1,000 
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1A and 1B), which was not observed in Ad-LacZ-infected control aHSC (comparison to 
un-infected control cells is not shown). The Ad-MnSOD-mediated increase in MnSOD 
mRNA levels was time-dependent and transient, peaking at 72 h after which it sharply 
dropped (Figure 1C). MnSOD protein levels, however, were only clearly increased after 
96h of infection (Figure 1D), indicating a significant delay between peak RNA levels and 
production of the corresponding protein. In the following experiments, effects of HSC 
activation were therefore analyzed 96 h after infection.
Figure 1. MnSOD expression is induced upon infection of hepatic stellate cells
A: After 72h of infection of aHSC with Ad-MnSOD (MOI 1000), MnSOD mRNA levels were 5-fold 
induced compared to Ad-LacZ-infected cells. * p<0.05 B: After 72h of Ad-MnSOD infection with a 
lower multiplicity of infection (MOI 500) there is hardly any induction of MnSOD mRNA levels. C: 
MnSOD mRNA levels are transiently increased with a maximum after 72h of infection. D: Protein 
levels of MnSOD are increased after 96h of Ad-MnSOD infection (MOI 1000).
Artificial overexpression of MnSOD reverses hepatic stellate cell activation
Adenoviral-mediated overexpression of MnSOD led to a strong reduction in mRNA 
levels of the typical HSC activation markers α-SMA (80% reduction), collagen1a1 (70% 










































(Figure 2A-C). In contrast, transcript levels for the marker for quiescent HSC, the 
nuclear receptor peroxisome proliferator-activated gamma (PPAR-y), were significantly 
increased (2.4-fold; Figure 2D). 
Figure 2. MnSOD induction results in a reversal to the quiescent phenotype of HSC 
Ad-MnSOD infection (MOI 1000) during 96h of aHSC caused an 80% reduction of α-smooth muscle 
actin (A), a 70% reduction of collagen 1α1 (B) and a 70% reduction of transforming growth factor-β 
(C) mRNA levels compared to Ad-LacZ infected aHSC. D: Upon MnSOD induction mRNA levels 
of peroxisome proliferator-activated gamma were increased 2.4 fold compared to AdLacZ-infected 
aHSC. * p<0,05.
Immunofluorescence microscopy
Next, we analyzed the Ad-MnSOD-infected aHSC by immunofluorescence microscopy in 
order to determine the activation status of HSC at the cellular level. Approximately 50% 
of the cells showed clearly increased levels of MnSOD that colocalized with Mitotracker, 
indicating proper targeting of the recombinant protein in HSCs (Figure 3A). The HSC with 
increased MnSOD expression appeared smaller in size. Double staining for intracellular 
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MnSOD. (Figure 3B). A similar effect was observed for α-SMA staining, which revealed 
that the cells with higher MnSOD levels show a decreased α-SMA expression. Moreover, 
the typical filamentous pattern of α-SMA in aHSC is largely absent. (Figure 3C)
Figure 3. Upon induction of MnSOD, the phenotype of HSC changes
A: Approximately 50% of the cells showed clearly increased levels of MnSOD (in green) that 
colocalized with Mitotracker (in red). B: Cells with increased MnSOD expression levels (*, in 
red) show reduced intracellular collagen1α1 expression (in green) compared to cells with a lower 
expression level of MnSOD. All aHSC were infected for 96h with Ad-MnSOD (MOI 1000). C: 
Cells with increased MnSOD expression (*, in red) show reduced α-SMA (green) staining, with 
a disrupted filamentous structure compared to cells with a lower expression level of MnSOD. 
Magnification of all photos: 630x.
Effect on expression of other antioxidant enzymes
Artificial overexpression of MnSOD may change the expression of other antioxidant 
enzymes. However, CuZnSOD expression levels were not significantly different between 
Ad-LacZ and Ad-MnSOD infected aHSC. The increased levels of MnSOD potentially lead 
to increased conversion of superoxides to hydrogen peroxide and thus we analyzed the 
mRNA levels of antioxidants that are responsible for the detoxification of H2O2. Ninety 






















































(GPx1) were slightly reduced in Ad-MnSOD treated HSC compared to Ad-LacZ-infected 
control cells (Figure 4A-B). However, only the difference in Gpx1 expression levels 
between Ad-MnSOD- and Ad-LacZ-infected aHSC reached statistical significance.
Discussion
In this study, we show that recombinant expression of mitochondrial MnSOD in 
activated hepatic stellate cells reduces their activation state, as indicated by reduced 
collagen1α1 and α-SMA expression. MnSOD levels in aHSC thus directly control their 
fibrogenic potential and increasing MnSOD expression in chronic liver disease may 
therefore reduce liver fibrosis. 
Concomitant with the reduction of collagen1α1 and α-SMA mRNA levels, PPAR-γ 
expression was increased in MnSOD-overexpressing aHSC. PPAR-γ is a central factor in 
HSC transdifferentiation and its expression is strongly suppressed in aHSC compared 
to quiescent HSC (qHSC).(18,19) As PPAR-γ is an adipogenic transcription factor, it 
controls adipocyte specific genes, expressed by the quiescent hepatic stellate cells.
Figure 4. Expression levels of other 
antioxidants are hardly changed in MnSOD-
overexpressing aHSC
CuZnSOD (A) and Catalase (B) mRNA 
expression levels in Ad-MnSOD-infected 
aHSC do not differ from the AdLacZ-infected 
aHSC. GPx1 (C) mRNA expression levels are 
moderately decreased (-30%) in Ad-MnSOD 
infected cells compared to Ad-LacZ-infected 








































Overexpression of manganese superoxide dismutase reverses hepatic stellate cell activation
85
4
(20,21) Our data suggest that PPAR-γ expression is induced by MnSOD. From previous 
studies, it is known that PPAR-γ expression is influenced by oxidative stress.(22,23) As 
we speculate that induction of MnSOD expression influences the oxidative stress levels 
in hepatic stellate cells, PPAR-γ expression could be influenced in this way. However, 
another possibility is that MnSOD triggers quiescence through other pathways, by which 
PPAR-γ is induced. The human SOD2 gene contains a PPAR-γ binding motif (PPRE) 
in the promoter region; however, this was shown to suppress MnSOD expression.(24) 
The promoter of rat SOD2 also contains PPRE elements, though they are not completely 
homologous to those found in the human promoter. Still, it is likely that PPAR-γ also 
influences rat MnSOD expression. From our experiments, we conclude that PPAR-γ 
and MnSOD stimulate each other in a positive direction, since both MnSOD and 
PPAR-γ decrease upon activation of HSC and increase again upon artificial induction 
of quiescence. To support this hypothesis, MnSOD expression levels should be assessed 
upon stimulation of aHSC with PPAR-γ agonists.
Along with MnSOD induction, a decrease in (mitochondrial) superoxides is expected, 
and a potential increase of hydrogen peroxide (since catalase and GPx1 mRNA levels 
are slightly decreased). This switch in ROS can possibly lead to altered physiological 
signaling, resulting in a reduced activation state of the stellate cells. Previously, it was 
shown that superoxide production is linked to proliferation and that SOD mimetics 
were able to block this.(25) Since activated hepatic stellate cells are highly proliferative, 
decreased superoxide levels due to the induced MnSOD expression may lead to reduced 
HSC activation. Furthermore, it has been described that MnSOD levels induce transition 
between quiescent and proliferative growth in embryonic fibroblasts; high levels of 
MnSOD and low superoxide levels are associated with quiescence whereas low levels 
of MnSOD with high superoxide levels are associated with proliferation.(26) Although 
different cells were used, the similarities concerning the transdifferentiation from 
quiescent to proliferative cells are notable, and therefore this mechanism could also 
be true for hepatic stellate cells. Future experiments to investigate these mechanisms 
further should include assessment of superoxide and hydrogen peroxide levels as well 
as proliferation assays.
It is suggested that HSC activation is accompanied with a major change in 
mitochondrial function, since they switch from oxidative phosphorylation to glycolysis, 
while the number of mitochondria is retained (known as the Warburg effect).(27) 










































Increasing MnSOD expression, leading to reduced mitochondrial superoxides, could 
lead to reduced mitochondrial stress and possibly increase oxidative phosphorylation. 
Induction of MnSOD was shown to reduce the growth rate of multiple types of cancer 
cells (29), as well as inhibit lipid peroxidation. As activated stellate cells share many 
similarities with cancer cells, such as proliferation and a change in metabolism (Warburg 
effect), we hypothesize that the protective mechanism of MnSOD induction is similar in 
HSCs and cancer cells, and possibly is associated with improved mitochondrial function. 
In order to get more evidence for this hypothesis, future experiments should include 
measurements of oxidative phosphorylation in aHSC with or without induction of 
MnSOD levels.
Previous studies showed that in vivo overexpression of MnSOD was protective in 
both cholestatic liver injury and alcohol liver disease, probably through a reduction of 
mitochondrial oxidative stress.(11,12) However, in these in vivo experiments, adenoviral 
gene delivery most likely is targeted to the hepatocytes, the main liver cell type. 
Therefore, the effects described in these studies are unlikely related to the repression of 
HSC activation. Apparently, there is dual effect of MnSOD, both protecting hepatocytes 
from oxidative stress and preventing hepatic stellate cells from activating.
In summary, we conclude that MnSOD induction in activated rat hepatic stellate 
cells reverses stellate cell activation. This provides further evidence to the concept that 
oxidative stress, especially mitochondrial reactive oxygen species, plays an important 
role in liver fibrosis.
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Introduction Caffeine is known from previous epidemiological studies to prevent the 
onset as well as aggravation of liver disease, including liver fibrosis. This was confirmed 
in in vivo studies in several models of liver disease, such as the cholestatic model of 
bile duct ligation, and the cytotoxic models CCl4 and TAA. It has been suggested that 
the antifibrotic and protective effects of caffeine are due to its metabolites, such as 
dimethylxanthines. However, a direct effect of caffeine has not been excluded and has 
never been investigated. 
Aim of the study was to investigate the effect of caffeine and its main metabolite on 
several cell types involved in liver fibrogenesis. 
Methods/results Primary rat hepatic stellate cells and portal myofibroblasts were culture-
activated and treated with either caffeine, its main metabolite 1,7-dimethylxanthine (1,7-
DMX) or the combination of these two. Markers of myofibroblast activation, such as 
alpha-smooth muscle actin (α-SMA), and collagen1 α 1, were reduced by both caffeine 
and 1,7-DMX, both at the mRNA (qPCR) and protein (Western blot, immunofluorescence) 
level up to 60% at a concentration of 20mmol/L of caffeine after 72h. The combination of 
caffeine and 1,7-DMX was able to reduce α-SMA and collagen1 α 1 mRNA levels even 
further. In addition, caffeine was able to reduce the proliferative capacity of the stellate 
cells. Since caffeine is to be metabolized by CYP1A2, we determined the expression 
levels in liver cells. It was hardly expressed in any cell type other than hepatocytes. 
Caffeine and 1,7-DMX also have anti-inflammatory properties, in primary Kupffer 
cells pre-incubation resulted in reduced LPS-induced TNF-α mRNA levels. In primary 
hepatocytes, pre-incubation with 1,7-DMX resulted in reduced cytokine mixture-induced 
iNOS mRNA levels.
Conclusion Caffeine is able to reduce activation as well as proliferation of stellate cells in 
vitro, independent of its main metabolite 1,7-DMX. However, in combination their effects 
are complementary. Moreover, caffeine and 1,7-DMX have anti-inflammatory properties. 












































Liver diseases can have a diverse etiology. Well known causes are hepatitis B or C 
infection, non-alcoholic fatty liver disease (NAFLD) associated with obesity, and alcohol 
abuse. Chronic liver disease can lead to liver fibrosis and its end stage liver cirrhosis. 
These are severe disorders, with high morbidity and mortality. Currently, no effective 
drug-based treatment is available to reverse or arrest fibrosis and/or cirrhosis. 
From epidemiological studies it is known that patients with liver fibrosis or cirrhosis 
caused by NAFLD and hepatitis C virus infection benefit from coffee consumption 
compared to non-coffee drinkers: the risk of liver disease progression was reduced as 
evaluated by biopsies and biochemical parameters.(1-4) The amount of coffee needed 
to achieve this risk reduction is unclear, however one study reported a consumption 
of more than two units a day to obtain a beneficial effect.(3) Explaining the observed 
protective effects, an anti-inflammatory mechanism was suggested, as well as reduced 
risk for diabetes mellitus type 2. Whether the beneficial effect observed from coffee can 
be attributed to caffeine is under debate: some studies do not find a negative (protective) 
correlation between caffeine and fibrosis (4), while others observed a protective effect 
of caffeine when comparing caffeinated and decaffeinated coffee (3). Several studies 
however, could not show a beneficial effect of black tea or other caffeinated beverages.
(1,2)
To confirm the observed beneficial effects in epidemiological studies, several studies 
were performed in in vivo models of liver disease. In cytotoxic liver disease induced 
by carbon tetrachloride (CCL4) grain coffee showed antifibrotic effects on biochemical 
and histological level.(5) Also lipid peroxidation was reduced which indicates an anti-
oxidative effect. In another cytotoxic liver disease model, induced by thioacetamide 
(TAA), the effect of caffeine as an ingredient of coffee was studied. Conventional coffee, 
and to a lesser extent decaffeinated coffee and caffeine separately reduced ALT (alanine 
transaminase, serum marker for hepatocyte necrosis) and histological scores for fibrosis 
and inflammation induced by TAA. However, only conventional coffee and caffeine 
induced a reduction of PCNA-S phase positive cells (proliferating cellular nuclear 
antigen, a marker for proliferation) expression, while only conventional coffee reduced 
metalloproteinase-2 (MMP2, a marker for fibrosis) activity. Thus, caffeine seems to have 
an independent effect on fibrosis, although the main effect is accomplished using the 










































steatohepatitis in a model of alcoholic liver disease.(7) Moreover in the same study, 
Kupffer cells isolated from mice with alcoholic liver disease treated with caffeine were 
less activated upon endotoxin (LPS)-induced activation. This supports the hypothesis 
that caffeine has independent protective effects on liver disease.
In cholestatic liver disease induced by bile duct ligation (BDL), caffeine and its main 
metabolite 1,7-dimethylxanthine (1,7-DMX) proved to be antifibrotic as well as to reduce 
lipid peroxidation.(8)
Few in vitro studies with caffeine and/or its metabolites have been performed on 
this subject, and they focused mainly on hepatic stellate cells. Upon chronic injury these 
cells transdifferentiate into myofibroblasts, producing extracellular matrix, the major 
hallmark of fibrosis. Caffeine and 1,7-DMX were found to reduce expression of profibrotic 
connective tissue growth factor (CTGF), whereas hepatocytes were not damaged by 
caffeine or 1,7-DMX.(8) Next to hepatic stellate cells, also portal myofibroblasts can 
contribute to extracellular matrix production. 
As fibrogenesis is accompanied by inflammation, it is also relevant to investigate the 
effect of caffeine (and its metabolites) on inflammatory cells such as Kupffer cells, the 
resident macrophages of the liver. Finally, caffeine (or its metabolites) can have effects 
on hepatocytes, the most predominant liver cell type. Hepatocytes are exposed to all 
incoming compounds from the gut via the portal circulation, including damaging stimuli 
and microbial/viral agents, possibly leading to hepatocyte death. Dying hepatocytes 
contribute to liver injury via different mechanisms: hepatocytes are the functional liver 
cell type and their death eventually leads to liver failure, but dying hepatocytes can also 
aggravate liver inflammation, by attracting inflammatory cells. 
In order to further clarify the protective effect of caffeine observed in epidemiological 
studies, and to further determine the in vitro mechanism of these protective effects, we 
investigated whether caffeine or its major metabolite has antifibrotic, anti-inflammatory 














































Specified pathogen-free male Wistar rats were purchased from Charles River 
Laboratories Inc. (Wilmington, MA, USA). Animals were kept under standard laboratory 
conditions with free access to standard laboratory chow and water. All experiments were 
performed in accordance with the guidelines of the local Committee for Care and Use of 
laboratory animals.
Hepatic stellate isolation
Hepatic stellate cells (HSCs) were isolated from male Wistar rats (500-600 g) by 
pronase (Merck, Amsterdam, the Netherlands) and collagenase-P (Roche, Almere, 
The Netherlands) perfusion of the liver, followed by Nycodenz (Axis-Shield POC, 
Oslo, Norway) gradient (13% w/v) centrifugation as described previously.(9) Hepatic 
stellate cells were cultured in Iscove’s Modified Dulbecco’s Medium with Glutamax 
(Invitrogen, Breda, The Netherlands) supplemented with 20% heat-inactivated fetal calf 
serum (Invitrogen), 1 mmol/L sodium-pyruvate (Invitrogen), 1x MEM non essential 
amino acids (Invitrogen), 50 µg/mL gentamycin (Invitrogen), 100 U/mL penicillin 
(Lonza, Vervier, Belgium), 10 µg/mL streptomycin (Lonza), 250 ng/mL fungizone 
(Lonza) in a humidified atmosphere containing 5% CO2 at 37 °C. Purity was checked by 
autofluorescence and phenotypical appearance.
Hepatocyte isolation
Hepatocytes were isolated from male Wistar rats (220-250g) by a two-step collagenase 
I perfusion as described previously.(10) Cell viability was greater than 85% as determined 
by Trypan Blue exclusion. After isolation, 112500 cells per cm2 were plated on Vitrogen® 
(Cohesion Technologies Inc., Palo Alto, CA, USA) coated plates in William’s E medium 
(Invitrogen, Breda, The Netherlands) supplemented with 50 μg/mL gentamycin 
(Invitrogen) and penicillin–streptomycin–fungizone (Lonza, Verviers, Belgium). During 
the attachment period (4 h) 50 nmol/L dexamethasone (Department of Pharmacy 
UMCG, Groningen, The Netherlands) and 5% fetal calf serum (Invitrogen) were added 











































Portal myofibroblasts were isolated from the residues of the portal tree after 
hepatocyte isolation (see above) as described earlier.(11) In short, the residues of the 
intrahepatic bile duct were minced and subsequently incubated for 30 min at 37°C in a 
digestion solution containing collagenase P (0,66%), pronase (0,055%), DNase (0,006%), 
fetal calf serum (3%), bovine serum albumin (0,1%), Hepes (10mmol/L) and penicillin-
streptomycin-fungizone (100000 IU-100mg/L). Next, the solution was filtered and the 
incubation step was repeated with a newly made digestion solution. Finally, the residues 
were incubated for 30 min at 37°C in a digestion solution where pronase was replaced by 
hyaluronidase (0,036%). After filtering and centrifugation to collect the cells, considered 
portal myofibroblasts, they were cultured in a humidified incubator at 37 °C and 5% CO2, 
and were allowed to proliferate until confluency was reached. The portal myofibroblasts 
were cultured in the same medium as hepatic stellate cells (see above): IMDM containing 
20% FCS. 
Kupffer cell isolation
Kupffer cells were isolated from the non-parenchymal cell fraction obtained after 
hepatocyte isolation. The Kupffer cells in this fraction were isolated using a Percoll 
density cushion, as described previously.(12) The cells were allowed to adhere to 
the culture plates for 30 min in HBSS containing Mg2+,Ca2+and 10% FCS. Next, the 
contaminating hepatocytes were removed by washing and cells were cultured overnight 
in RPMI containing 10% FCS in a humidified incubator at 37 °C and 5% CO2. Purity of 
the cell population was checked by ED-1 staining.
Experimental design
Activated hepatic stellate cells were used at passage 1, after 7 days of culture. Then 
the cells were incubated with the indicated concentrations of caffeine and/or 1,7-DMX. 
At the indicated time points the cells were harvested for the different assays.
Portal myofibroblasts were used at passage 2 to 3. The cells were incubated with the 
indicated concentrations of caffeine and/or 1,7-DMX and at the indicated time points 
the cells were harvested for the different assays. Portal myofibroblasts were cultured in 
serum containing medium throughout the experiments. 
Hepatocytes were pre-incubated for 0.5 hr with 1,7-DMX at the indicated 
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of interleukin 1β (IL-1β; 10 ng/ml), tumor necrosis factor-α (TNFα; 10 ng/ml) and 
interferon-γ (IFNy; 10 ng/ml). At the indicated time points cells were harvested for the 
different assays. 
Kupffer cells were pre-incubated for 0.5 hr with either 1,7-DMX or caffeine at the 
indicated concentrations. After the pre-incubation the cells were incubated with LPS 
(0.1µg/mL) for 5h. At the indicated time points cells were harvested for the different 
assays.
All the experiments were performed in serum free medium, unless indicated otherwise.
RNA isolation, RT-PCR and quantitative real time PCR
RNA was isolated using Tri-reagent (Sigma-Aldrich) according to the manufacturer’s 
instructions. Reverse transcription was performed on 1µg RNA using random nanomers 
(Sigma-Aldrich) in a final volume of 50 μL. Reverse transcription was performed in three 
steps: 10 minutes at 25°C, 1 hour at 37°C and 5 minutes at 95°C.
Real time detection was performed on the ABI PRISM 7700 (PE Applied biosystems) 
using the Taqman protocol. This protocol includes an initiation of 10 min at 95°C, 
followed by 40 cycles (15 seconds at 95°C, and 1 minute at 60°C). mRNA levels of 18S 
were used as an internal control. Each sample was analyzed in duplicate. Relative gene 
expressions were calculated using the ΔΔCt method. The primers (Invitrogen) and 










































Table 1 Primers and probes sequences used for real time qPCR
Gene Primers
18S Sense 5’-CGG CTA CCA CAT CCA AGG A-3’
Anti-sense 5’-CCA ATT ACA GGG CCT CGA AA-3’
Probe 5’-CGC GCA AAT TAC CCA CTC CCG A -3’
αSMA Sense 5’-GCC AGT CGC CAT CAG GAA C-3’
Anti-sense 5’-CAC ACC AGA GCT GTG CTG TCT T-3’
Probe 5’-CTT CAC ACA TAG CTG GAG CAG CTT CTC GA-3’
Collagen type 1 Sense 5’-TGG TGA ACG TGG TGT ACA AGG T-3’
Anti-sense 5’-CAG TAT CAC CCT TGG CAC CAT-3’
Probe 5’-TCC TGC TGG TCC CCG AGG AAA CA-3’
CYP1A2 Sense 5’-TCA CTG AAT GGC TTC CAC ATT C-3’
Anti-sense 5’-CTG GGC GGA ACA CAA AGG-3’
Probe 5’-CTT TCC ACT GCT TCT CAT CAT GGT TGA CCT-3’
iNOS Sense 5’-GTG CTA ATG CGG AAG GTC ATG-3’
Anti-sense 5’-CGA CTT TCC TGT CTC AGT AGC AAA-3’
Probe 5’-CCC GCG TCA GAG CCA CAG TCC T-3’
TGFβ Sense 5’-GGG CTA CCA TGC CAA CTT CTG-3’
Anti-sense 5’-GAG GGC AAG GAC CTT GCT GTA-3’
Probe 5’-CCT GCC CCT ACA TTT GGA GCC TGG A-3’
TNFα Sense 5’-GTA GCC CAC GTC GTA GCA AAC-3’




Western blot analysis of total cell lysates was performed by SDS-PAGE followed 
by semi dry-blotting to transfer the proteins to Hybond ECL nitrocellulose membrane 
(Amersham Biosciences, Piscataway, NJ, USA). Ponceau S 0.1 % w/v (Sigma-Aldrich, St. 
Louis, MO, USA) staining was used to confirm electrophoretic transfer and was used as 
a loading control. Protein expression of α-SMA was detected using an antibody against 
α-SMA (Sigma-Aldrich, St. Louis, MO, USA, mouse monoclonal, dilution 1:2000). The 
blots were analyzed in a ChemiDoc XRS system (Bio-Rad, Hercules, CA, USA). Protein 
band intensities were quantified by Image lab software (Bio-Rad, Hercules, CA, USA). 
Immunofluorescence
Activated HSCs were cultured on glass coverslips. After treatment, coverslips were 
fixed in 4% paraformaldehyde/PBS. Prior to staining, cells were permeabilized in 1% 
Triton-X100 for 5 minutes. Nonspecific antibody binding sites were blocked for 30 min 
in 0.5% BSA/PBS. Then, cells were incubated with primary antibodies (α-SMA: Sigma-
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1:30) for 1-2 hours. As secondary antibodies we used the Alexa fluorophores (Molecular 
Probes, diluted 1:500). Finally, coverslips were mounted in fluorescence mounting 
medium S3023 containing DAPI for nuclear staining (DAKO). The slides were visualized 
using the confocal laser scanning microscope (Zeiss 410 inverted laser scan microscope).
BrdU incorporation ELISA assay
Proliferation was measured using a BrdU incorporation ELISA assay (Roche 
Diagnostics, Almere, the Netherlands) according to the manufacturer’s instructions.
Real time proliferation assay
Real time proliferation of the myofibroblasts was assessed using an xCELLigence 
Real-time Cell Analyzer DP system (ACAE Biosciences, San Diego, USA), a system using 
electrical impedance as a measurement of both proliferation and stretching. When the 
cell number and/or size increase, impedance will increase. Per well 5000 cells were 
plated, after an attachment period of 4 hours cells were incubated with the indicated 
compounds.
Statistical analysis
All results are presented as the mean of at least three independent experiments 
using cells from different rats ± standard deviation. Statistical analysis of the results was 
performed using GraphPad Prism 5 for Windows. A student t-test or two-way ANOVA 
followed by Bonferroni’s multiple comparison tests were used to determine significant 
differences between the groups. A p-value <0.05 was considered statistically significant. 
Results
Caffeine reduces α-SMA and collagen-1α1 mRNA as well as protein expression in hepatic stellate 
cells and in portal myofibroblasts
Upon treatment with caffeine for 72h both hepatic stellate cells and portal 
myofibroblasts showed reduced mRNA expression of the fibrogenic markers α-SMA 
and collagen type 1 mRNA (Figure 1). Also at the protein level, α-SMA and collagen 
type 1 expression were reduced upon treatment with caffeine. Using Western blot and 
immunofluorescence staining, we were able to show a decrease of α-SMA compared to 
untreated cells (Figure 2A-B). Collagen type 1 expression disappeared almost completely 










































Figure 1. Caffeine reduces α-SMA as well as collagen mRNA levels in hepatic stellate cells as 
well as in portal myofibroblasts
A Hepatic stellate cells show reduced α-SMA and collagen 1α1 mRNA levels after 48h and 72h 
treatment with caffeine. * p<0.05 compared to untreated 48h; # p<0.05 compared to untreated 72h.
B Portal myofibroblasts show reduced α-SMA and collagen 1α1 mRNA levels after 72h treatment 
with caffeine. * p<0.05 compared to untreated.
Caffeine reduces proliferation of hepatic stellate cells and portal myofibroblasts
In addition to markers of fibrogenesis, we investigated the effect of caffeine on the 
proliferation of stellate cells. Treatment of caffeine decreased proliferation of already 
activated stellate cells as shown by decreased BrdU incorporation. In addition, caffeine 
also prevented the proliferation of quiescent stellate cells during culture-activation 
(Figure 3A). The proliferation during the culture-activation process was visualized 
using the xCELLigence, and we observed a dose-dependent decrease of the proliferation 
rate upon treatment with caffeine. Upon halting caffeine treatment, hepatic stellate cells 
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Figure 2. Caffeine reduces α-SMA as well as collagen protein levels in hepatic stellate cells
A Reduced α-SMA expression in hepatic stellate cells treated for 72h with indicated concentrations 
of caffeine. A representative blot of n=3 is shown. Loading control: Ponceau S staining.
B Immunofluorescent staining shows a decreased expression of α-SMA in hepatic stellate cells 
treated for 72h with 20mmol/L of caffeine. α-SMA staining in green, nuclear DAPI staining in blue. 
Magnification 630x.
C Immunofluorescent staining shows a decreased expression of collagen type 1 in hepatic stellate 
cells treated for 72h with 20mmol/L of caffeine. In green collagen type 1 staining, in blue nuclear 










































Figure 3. Proliferation of hepatic stellate cells is reduced upon treatment of caffeine
A In the left panel activated HSCs were incubated with different concentrations of caffeine for 
72h. In the right panel, quiescent HSCs were incubated with different concentrations of caffeine 
during the first 5 days after isolation. Proliferation was assessed using a BrdU incorporation ELISA. 
Representative graphs of n=3 are shown.
B Real time monitoring of proliferation and growth of quiescent stellate cells incubated with caffeine 
undergoing culture-activation. Caffeine treatment can dose-dependently inhibit proliferation 
compared to untreated cells, but upon halting caffeine treatment the stellate cells are able to 
continue proliferating. Representative graph of n=3 is shown.
The metabolite of caffeine, 1,7-dimethylxanthine is also able to reduce α-SMA and collagen type 
1 expression
Since it was shown previously that caffeine exerts its antifibrotic effect via its main 
metabolite, 1,7-dimethylxanthine (DMX) in hepatocytes and hepatic stellate cells, we 
determined whether this effect could be reproduced. The effects of 1,7-DMX on α-SMA 
and collagen type 1 expression were similar to the effects observed with caffeine. 
Moreover, the combination of caffeine and 1,7-DMX further enhanced the reduction of 
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Figure 4. 1,7-DMX and caffeine have complementary effects reducing activation markers of 
activated hepatic stellate cells
Treatment of activated hepatic stellate cells during 72h with either 1 mmol/L 1,7-DMX or 20 
mmol/L caffeine reduce α-SMA as well as collagen 1α1 mRNA expression compared to untreated 
cells. The combination of caffeine and 1,7-DMX reduces α-SMA and collagen 1α1 mRNA expression 
even further compared to caffeine alone. *p<0.05.
Mechanism of action
Caffeine is metabolized in the liver by hepatocytes through the enzyme cytochrome 
P450 1A2 (CYP1A2). To study whether our observed effects in stellate cells were caused 
by direct effects of caffeine or by its metabolite, we determined the expression of this 
enzyme in hepatic stellate cells and portal myofibroblasts. Compared to primary 
hepatocytes, both hepatic stellate cells and portal myofibroblasts hardly express CYP1A2 
(>1000 fold less than hepatocytes), making the possibility of caffeine metabolism in HSCs 
and PMFs highly unlikely (Figure 5).
Figure 5. Activated hepatic stellate cells as well as portal myofibroblasts hardly express CYP1a2
Compared to hepatocytes there is hardly any expression of CYP1A2 mRNA in HSCs, PMFs and 
KCs (1000-fold difference). Results are shown in 2-ΔCT values, where Δ refers to the correction of 










































Caffeine and 1,7-DMX have anti-inflammatory properties
Inflammation plays an important role in fibrogenesis. Therefore, we also investigated 
the effect of caffeine and its main metabolite on Kupffer cells and hepatocytes. Kupffer 
cells pretreated with caffeine or 1,7-DMX showed reduced induction of LPS-induced 
TNF-α mRNA expression, with a more pronounced effect of caffeine (Figure 6A).
When hepatocytes were pre-incubated with 1,7-DMX before exposure to an 
inflammatory cytokine mixture composed of TNF-α, IL-1β and IFN-γ, the expression of 
cytokine mixture-induced iNOS mRNA was attenuated (Figure 6B).
A B
Figure 6. 1,7-DMX and caffeine show anti-inflammatory effects 
A Kupffer cells pretreated with 1,7-DMX (1mmol/L) or caffeine (20mmol/L) for 30 minutes have 
reduced LPS-induced TNF-α mRNA levels compared to LPS (0.1µg/mL) treatment alone. *p<0.05 
compared to LPS-treated cells.
B Pretreatment of primary hepatocytes with 1,7-DMX (1mmol/L) reduces cytokine mixture-
induced iNOS mRNA expression levels compared to cytokine mixture treatment alone. *p<0.05 
compared to cytokine mixture-treated cells.
Discussion
In this study, we demonstrate that caffeine has both a direct as well as an indirect 
antifibrotic effect. This is in line with literature, where effects of both caffeine and 
1,7-dimethylxanthine have been described. The novelty of our data is that these effects 
are complementary and mediated via different pathways. Moreover, we demonstrate 
that caffeine has effects on additional cell types involved in liver fibrogenesis, such as 
Kupffer cells and hepatocytes. 
Caffeine can have multiple effects, of which the most known is its function as a 
pan-adenosine receptor antagonist. Therefore, it is likely that the reduction of stellate 
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is confirmed in earlier studies, where it was shown that adenosine occupancy of the 
adenosine A2a receptor, the adenosine receptor present on HSCs, stimulates collagen 
production.(13) Also in dermal fibrosis, adenosine was implicated as a main contributor 
of extracellular matrix production.(14) 
In our study, the effects of 1,7-DMX and caffeine treatment on hepatic stellate cells 
are similar. Since there is no CYP1A2 expression in hepatic stellate cells to metabolize 
caffeine, there must be an indirect effect of caffeine as well. When caffeine is metabolized 
by hepatocytes, via the enzyme CYP2A1, three metabolites are produced; 1,7-DMX 
(or paraxanthine), theobromine and theophylline. 1,7-DMX is the main metabolite, 
representing 80% out of all the metabolites. It has been shown before that 1,7-DMX is able 
to reduce fibrogenic factors, like transforming growth factor-β (TGF-β) and connective 
tissue growth factor (CTGF), although the exact mechanism remains to be clarified. 
A well-known derivative of theobromine is pentoxifylline, a phosphodiesterase 
inhibitor known to inhibit tumor necrosis factor–α (TNF-α) synthesis by increasing 
intracellular cAMP concentrations.(15) Previously, it was shown that pentoxifylline is 
able to decrease proliferation (16) and collagen production (17) of hepatic stellate cells. 
Randomized controlled trials have also shown a beneficial effect of pentoxifylline 
treatment in liver disease, for example complications in advanced liver cirrhosis were 
reduced (18) and short-term survival in patients with severe alcoholic hepatitis was 
improved (19).
It is known that caffeine antagonizes adenosine receptors at low concentrations (20). 
The concentrations we used, up to 20 mmol/L, are at the high end of the range. At high 
concentrations caffeine is known to act as a phosphodiesterase inhibitor. As described 
above, this could result in anti-inflammatory effects, due to increased intracellular cyclic 
adenosine monophosphate (cAMP) concentrations, which inhibits TNF-α synthesis.(21) 
We observe similar anti-inflammatory effects in Kupffer cells and hepatocytes. However, 
whether these anti-inflammatory effects are beneficial in chronic liver disease remains 
to be elucidated, since it has been described that caffeine may also exacerbate liver 
inflammation by inhibiting adenosine receptors, which are critical in immune cells in 
the production of pro-inflammatory cytokines needed to exert physiological effects.(22)
Numerous reports suggest coffee as an anti-oxidant (23-26), however, whether 
this is due to caffeine and its metabolites is unclear. Next to caffeine, there are many 










































oxidative properties of coffee. For example, the diterpenes cafestol and kahweol, absent 
in filtered coffee, have been shown to induce glutathione and HO-1 levels through Nrf2 
(nuclear factor erythroid 2-related factor)-mediated gene regulation, thereby protecting 
against oxidative damage. (27) However, there is also evidence that these ingredients are 
responsible for raising LDL (low-density lipoprotein) cholesterol.(28) Other important 
ingredients of coffee are chlorogenic acids. These are presumed to be major antioxidants, 
by inhibiting reactive oxygen species, as well as scavenging them.(29) Also anti-
inflammatory effects of chlorogenic acids have been described, for example inhibition of 
LPS-induced cyclooxygenase-2 (COX-2) expression in macrophages, resulting in reduced 
prostaglandin E2 expression.(30) However, negative effects have been described as well, 
such as increased homocysteine levels, associated with atherosclerosis.(31) To determine 
the effect of coffee, future experiments should include incubation of liver myofibroblasts 
with a raw extract of coffee as well as the ingredients described above.
To summarize, from this study we conclude that caffeine exerts both a direct as well 
as an indirect antifibrotic effect in vitro. Moreover, we confirmed its anti-inflammatory 
action in our in vitro model of Kupffer cells and hepatocytes stimulated with cytokine 
mixture. This study provides further evidence for protective actions of caffeine, and 
possibly coffee, in patients with liver disease.
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Chronic liver disease is a major health burden, often resulting in fibrosis or its end 
stage cirrhosis, irrespective of the etiology. A chronic wound healing response occurs 
upon persisting injury, which causes hepatocytes to die. However, myofibroblasts, 
responsible for the deposition of extracellular matrix, flourish. Possibly, adaptive 
mechanisms of myofibroblasts (mainly originating from stellate cells) can explain this 
paradox. One of these mechanisms could be an altered anti-oxidant status, as oxidative 
stress plays a major role in fibrogenesis.
In this thesis, we aimed to investigate the mechanism(s) of hepatic stellate cell 
activation focusing on the role of oxidative stress and anti-oxidant mechanisms, in order 
to contribute to a stellate cell-targeted therapy for liver fibrosis.
In chapter 2, we investigated the role of heme oxygenase-1 (HO-1) in cells most 
intimately involved in liver fibrogenesis: hepatic stellate cells and macrophages. HO-1 
is an enzyme heavily involved in oxidative stress. Previously, we have shown that HO-1 
induction can protect hepatocytes from superoxide-induced cell death.(1) Since there are 
also reports that HO-1 is antifibrotic and immunomodulatory, we investigated the role of 
HO-1 in in vitro cultures of hepatic stellate cells and macrophages. 
The main finding of this study was that HO-1 appears to be antifibrotic due to its 
immunomodulatory effects, since we showed that HO-1 induction in macrophages 
changes the phenotype of the macrophages to the pro-inflammatory M1 phenotype, 
while markers of the tissue remodeling and profibrotic M2 macrophage phenotype 
are decreased. This suggests that HO-1 is able to regulate the actions of macrophages, 
which can then orchestrate other cells, for example myofibroblasts. To unequivocally 
demonstrate that HO-1 is antifibrotic via immunomodulatory effects, a co-culture system 
of hepatic stellate cells and Kupffer cells in which HO-1 expression is induced should be 
established. Alternatively, an in vivo model of liver fibrosis, with specific induction (or 
knockout/down) of HO-1 in Kupffer cells, could be developed. 
The fact that the phenotype of the macrophages is changed to the pro-inflammatory 
M1 phenotype appears to be an undesired response at first glance. However, we 
hypothesize that an initial induction of inflammation is favourable over a profibrotic 
response, because it will accelerate the resolution and/or clearance of the causative 
agent of the inflammatory reaction, thereby limiting long-term activation of stellate cells 
and fibrosis. This is supported by recent reports that show an increased phagocytosis 
and bacterial clearance of macrophages upon HO-1 induction.(2-4) In order to further 










































in vivo liver disease model, with or without induction of HO-1 or in conditional HO-1 
knockout mice. 
The origin of macrophages involved in fibrogenesis has to be studied in more 
detail, as different subsets of macrophages exist in liver disease.(5) The increase of ED-1 
expression we observed in our study could originate from an increase of extrahepatic 
macrophages migrating to the liver from, for example, the bone marrow. It will be of 
interest to know whether these extrahepatic macrophages behave differently compared 
to resident Kupffer cells. A recent study showed that dendritic cells do not play a role in 
liver fibrosis.(6)
Taking into account that our previous study showed a protective effect of HO-1 in 
hepatocytes against superoxide anion-induced cell death, HO-1 emerges as a central 
beneficial enzyme. The mechanisms of all these protective actions are not yet fully 
elucidated. HO-1 is responsible for the enzymatic conversion of heme into carbon 
monoxide, free iron and biliverdin. We previously showed that HO-1 protects hepatocytes 
via carbon monoxide (CO).(1) It is likely that in other cell types the protective mechanism 
of HO-1 is similar to that of hepatocytes. To study this, Kupffer cells should be cultured 
in a CO-containing atmosphere, or incubated with CO-releasing molecules (CORMs). 
There is evidence that CO is also responsible for HO-1-mediated actions in macrophages.
(2-4) Another suggested mechanism is protection by biliverdin, to which antioxidative 
properties are attributed.(7) 
In chapter 2, we focused on extracellular oxidative stress as part of an inflammatory 
response, which therefore is a main driving force for fibrosis. Intracellular oxidative 
stress is believed to play a role in the activation of hepatic stellate cells as well, and since 
the liver paradox can possibly be explained by different adaptive mechanisms to this 
intracellular oxidative stress, we focused on these mechanisms in chapter 3 and 4.
In chapter 3, we investigated the role of antioxidant systems in the resistance of 
activated hepatic stellate cells against ROS-induced toxicity, in particular hydrogen 
peroxide and superoxide anions. Hydrogen peroxide can be processed by catalase and 
glutathione peroxidase into water and oxygen. In this study, we demonstrate that upon 
activation of stellate cells intracellular glutathione content and glutathione peroxidase 
are increased, accompanied by a dramatic decrease of catalase and mitochondrial 
manganese superoxide dismutase (MnSOD) protein levels. 
Expression of Glutathione peroxidase 1 (GPx1) is increased upon activation, resulting 
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glutathione into oxidized glutathione, thereby neutralizing hydrogen peroxide. The 
fact that glutathione is essential for the activity of GPx1 can explain the complementary 
increase of glutathione upon HSC activation. Previous studies have shown that GPx1 
overexpression leads to a protection against oxidative stress-induced damage.(8-10) On 
the other hand, catalase protein expression drops dramatically upon HSC activation. 
Possibly, the increase of glutathione and GPx1 during the activation of HSCs is more 
important than the decrease of catalase in the detoxification of hydrogen peroxide. 
Blocking catalase and GPx activity separately or in combination resulted in sensitization 
of stellate cells to apoptosis, which was further increased upon exposure to hydrogen 
peroxide. Apparently, both enzymes play a key protective role against apoptosis in 
activated hepatic stellate cells even though catalase levels are very low.
Depletion of glutathione resulted in increased hydrogen peroxide-induced necrosis, 
which contrasts to the caspase-3-dependent apoptosis upon inhibiting catalase and 
GPx1 activity. This could be explained by a changed redox state upon the combination of 
glutathione depletion and exposure to reactive oxygen species, as glutathione is the most 
important regulator of the redox state.(11,12) Therefore, glutathione is indispensable for 
apoptosis as a change in the redox state probably affects the activity of caspases, because 
this requires reduced sulfhydryl groups.(13)
The study described in Chapter 3 demonstrates an adaptive mechanism of stellate 
cells acquired during their activation process. The increase in glutathione makes stellate 
cells more resistant to necrotic cell death, while preserving the potential to undergo 
apoptotic cell death. This could explain the feature of apoptotic clearance of hepatic 
stellate cells during the resolution of fibrosis.
The decrease in MnSOD expression does not appear to fit in this hypothesis of 
adaptation to a hostile pro-oxidant environment. Reactive oxygen species in liver 
fibrogenesis consist of hydrogen peroxide, but also superoxide and hydroxyl radicals. 
Apparently, HSC are adapted to deal with hydrogen peroxide, however, their defense 
against superoxides appears weak with reduced MnSOD en unchanged CuZnSOD 
expression.
Therefore in chapter 4, we further studied the role of MnSOD in hepatic stellate 
cells and we investigated the feasibility of reversing the phenotype of activated hepatic 
stellate cells to a quiescent phenotype by inducing MnSOD levels. The main finding of 
this study was that artificial overexpression of MnSOD led to decreased expression of 










































Previously, it was shown that in two different in vivo models of liver disease, 
cholestatic (14) and alcoholic liver disease (15), adenoviral-mediated overexpression of 
MnSOD attenuated liver injury. Hepatocyte death was inhibited, as shown by a reduction 
of biochemical markers, and fibrosis was reduced as well. Moreover, lipid peroxidation 
as well as the inflammatory response was reduced. The protective effects described in 
these studies are most likely due to direct effects of MnSOD induction in the hepatocytes. 
With induced MnSOD levels, these cells are better equipped to handle damaging stimuli 
and therefore the inflammatory response, and as a result fibrosis, will be reduced. In our 
study, however, we have shown that MnSOD induction in hepatic stellate cells can also 
protect against liver fibrosis. Thus, MnSOD can play a general protective role in liver 
disease.
The decrease of MnSOD levels upon HSC activation was a surprising finding, which 
appears to contradict our hypothesis that stellate cells have an increased resistance to 
reactive oxygen species, as MnSOD is required to detoxify superoxide anions produced 
in the mitochondria. However, there are several hypotheses to explain this apparent 
contradiction and they will be discussed in the following paragraphs.
Recently, it was shown that stellate cells switch their metabolism during activation 
from oxidative phosphorylation to aerobic glycolysis.(16) During this metabolic shift the 
number of mitochondria is retained, and even increased upon activation when comparing 
activated HSC to freshly isolated quiescent HSC. This is known as the Warburg effect, 
which is commonly observed in cancer cells. Interestingly, MnSOD expression is also 
reduced in cancer cells.(17) 
It is suggested that this is due to an increased demand for mitochondrial ROS to 
stabilize hypoxia inducible factor-1α (HIF-1α) expression (18), which is required to 
promote the Warburg effect (19,20) and is therefore indispensable for creating a survival 
advantage. The survival advantage of glycolysis for cancer cells lies in a shortage of 
oxygen for aerobic oxidative phosphorylation in the hypoxic microenvironment of a 
tumor.(21) In liver diseases, the microenvironment is also relatively hypoxic and it is 
believed that hypoxia contributes to the activation of hepatic stellate cells (22). Hepatic 
stellate cells are exposed to hypoxia during the isolation procedure and we hypothesize 
that MnSOD levels drop during activation as a result of this hypoxia. This would 
then lead to a shift in metabolism, which provides advantages for the myofibroblast 
phenotype of the stellate cell (for example proliferation). Induction of MnSOD levels 
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change the activated phenotype of stellate cells to a quiescent phenotype. A strategy to 
test this hypothesis would be to increase the oxygen concentration during isolation and 
culture. According to our hypothesis, MnSOD expression should then not decrease and 
the hepatic stellate cells should not undergo culture-activation.
However, it has also been reported that the Warburg effect in cancer cells is caused 
by the changed requirements of the cell rather than hypoxia.(23) Although aerobic 
glycolysis appears to be inefficient as only four adenosine triphosphate (ATP) molecules 
are produced (instead of thirty six), all the energy and biomass that is not used to make 
ATP in the oxidative phosphorylation can be used for nucleotide and lipid production. 
If MnSOD would lead to a change in metabolism back to oxidative phosphorylation, 
proliferation would decrease/cease as there are not enough means to provide for 
constant mitosis.
Another effect of induction of MnSOD expression could be an increase in the 
production of hydrogen peroxide as more superoxides are converted into hydrogen 
peroxide. As we have shown in chapter 3, stellate cells have an increased resistance 
against hydrogen peroxide-induced cell death, due to an increase in glutathione and 
glutathione peroxidase 1 content. Therefore, we do not expect cell death regardless of 
high concentrations of hydrogen peroxide, especially since we did not observe increased 
cell death upon induction of MSOD levels. Moreover, hydrogen peroxide is described 
as a cell signaling molecule (24), and we previously observed a reduced proliferation of 
stellate cells upon hydrogen peroxide treatment (25). This is confirmed by other studies in 
which a redox control of the cell cycle has been described: a reduction of MnSOD results 
in increased superoxide generation and decreased hydrogen peroxide exposure, which 
is associated with entry into the S-phase of the cell cycle. On the other hand, an increase 
of MnSOD levels, and thereby a decrease of superoxide anion generation and increased 
exposure to hydrogen peroxide, results in cell cycle exit and quiescence/senescence of 
the cell.(26) This mechanism was established in embryonic myofibroblasts and it seems 
likely that this also holds true for hepatic stellate cells.
Caffeine appears to have antifibrotic properties in epidemiological human (27-30) 
and in vivo animal studies (31-34). Therefore, in chapter 5 we investigated the effect of 
caffeine in vitro on hepatic stellate cells and macrophages. The main finding of this study 
was that both caffeine and its main metabolite 1,7-dimethylxanthine (1,7-DMX) have an 
antifibrotic effect in vitro. These effects are additive, but probably mediated via different 
pathways, since we showed that both HSCs and PMFs have hardly any expression of the 










































The observed additive antifibrotic effect of 1,7-DMX and caffeine in hepatic stellate 
cells and portal myofibroblasts can be explained by a dual effect. On the one hand 1,7-
DMX can act directly on myofibroblasts by inhibiting connective tissue growth factor 
(CTGF) and TGF-β expression as described earlier.(33,35) On the other hand caffeine can 
act directly on myofibroblasts via different mechanisms as will be explained in the next 
paragraphs. 
Caffeine is known for its capacity to act as a pan-adenosine receptor antagonist (36), 
and these receptors are known to play a role in fibrosis (37). HSC express the adenosine 
2a (A2a) receptor and it was previously shown that activation of this receptor causes 
activation of the stellate cells leading to increased collagen production.(38,39) Specific 
inhibition of this adenosine receptor in hepatic stellate cells could demonstrate if caffeine 
exerts its effects via adenosine receptor inhibition. However, it is known that only at low 
concentrations caffeine acts as a pan-adenosine receptor antagonist.(36) Since fairly high 
concentrations were used in our studies, it is unlikely that adenosine receptor antagonism 
is responsible for the observed effects of caffeine in hepatic stellate cells.
At high concentrations, caffeine can act as a phosphodiesterase (PDE) inhibitor (36), a 
pathway known to result in anti-inflammatory effects via the inhibition of TNF-α synthesis 
(40,41). Moreover, previous studies showed that the PDE inhibitor pentoxifylline, a 
derivative of theobromine (another metabolite of caffeine), is antifibrotic both in vitro 
in HSCs and also in vivo.(42-45) This could also be an explanation for the observed 
antifibrotic effect of caffeine in our study. Pentoxifylline is already used in clinical 
treatment of alcoholic liver disease, in order to prevent the hepatorenal syndrome.(46)
In addition we show an anti-inflammatory effect of 1,7-DMX pretreatment in 
hepatocytes and 1,7-DMX and caffeine pretreatment in LPS-stimulated Kupffer cells. 
This could result in an indirect antifibrotic effect by reducing the inflammatory response 
involved in fibrogenesis. Therefore, caffeine may protect against liver fibrosis by acting 
on multiple liver cell types.
Other ingredients of coffee (other than caffeine) are believed to have antioxidant 
properties, for example diterpenes and chlorogenic acids. Diterpenes are suggested to 
induce glutathione and HO-1 levels, protecting against oxidative damage.(47) In chapter 
2, we showed that an induction of HO-1 did not have a direct antifibrotic effect on 
stellate cells, but rather an indirect effect via modulation of the inflammatory response. 
Increased glutathione content is beneficial for the redox status of the cell, and as we have 
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Therefore, we hypothesize that the antifibrotic effect of diterpenes in stellate cells is 
not very important, and that beneficial effects of diterpenes are especially due to anti-
inflammatory mechanisms. 
Chlorogenic acids are suggested to act as antioxidants via the ability to reduce 
reactive oxygen species production as well as scavenging radicals.(48) Moreover, 
they are also thought to have anti-inflammatory effects, via the inhibition of LPS-
induced cyclooxygenase-2 (COX-2) expression in macrophages.(49) Therefore, it will 
be interesting to investigate the effect of chlorogenic acids on stellate cells directly, in 
order to find alterations in the anti-oxidant system, as well as to study their possible anti-
inflammatory potential on Kupffer cells. 
From bench to bedside? Clinical/translational perspectives
This thesis describes basic research on stellate cells, however, our final goal is to 
develop a stellate cell-targeted therapy for patients who suffer from liver fibrosis, or who 
are prone to develop fibrosis (for example patients with steatohepatitis). Therefore, in 
this final paragraph some possible translational mechanisms are described.
This thesis once again describes that fibrogenesis is a complicated process, with 
multiple factors playing a role. Instead of solely focusing on the reversal of the activated 
phenotype of stellate cells to a quiescent one, the hostile microenvironment should 
also be considered. Inflammation and macrophages in particular, play(s) a decisive 
role in maintaining a profibrogenic microenvironment. Therefore, the reversal of only 
HSC activation will not contribute to diminish fibrosis as long as the profibrogenic 
environment is maintained. On the other hand, therapies that focus only on reducing 
inflammation have shown to be ineffective as well. Therefore, development of a therapy 
aimed at both aspects should be pursued.
Treatment with heme oxygenase-1 is a good example of this. Although it does not 
have a direct antifibrotic effect on stellate cells, its in vivo protective properties could be 
explained by immunomodulatory effects. Therefore, future studies should focus on the 
direct effect of the altered phenotype of macrophages on the activation of hepatic stellate 
cells. As the protective effect of HO-1 seems to be a general phenomenon in liver disease, 
induction of HO-1 or (local) administration of carbon monoxide (the main protective 










































Increased resistance of stellate cells against oxidative stress and cell death is crucial to 
consider when developing a therapy to eliminate activated stellate cells from the fibrotic 
liver. Furthermore, it is important to consider that stellate cells have increased resistance 
to necrosis, but can still be susceptible to apoptotic cell death. When targeting stellate 
cells with a therapy aimed to kill them, hepatocyte protection should be considered. 
Furthermore, the effect of dying hepatic stellate cells on the microenvironment, for 
example by provoking a new inflammatory response, should be considered as well.
As stellate cells resemble cancer cells in several aspects, i.e. their ability to 
proliferate, change metabolism etc., a similar therapeutic approach can be considered. 
Chemotherapeutic agents developed to specifically target cancer cell characteristics, for 
example their proliferation or glycolytic metabolism, can also be very useful to eliminate 
stellate cells. However, the major disadvantage of chemotherapeutic agents are the severe 
side effects, especially when these agents have to be administered to patients whose liver 
is damaged, but who are still unsure of actually developing liver cirrhosis. 
The most obvious clinically relevant study of this thesis is the study on the effect of 
caffeine on several cell types involved in liver fibrosis. This project started with a clinical 
question: why is coffee or caffeine associated with a lower incidence of fibrosis? We show 
that caffeine can have protective effects via multiple mechanisms: directly via inhibition 
of proliferation and activation of myofibroblasts and indirectly via reduction of the 
inflammatory response. This study can contribute to the development of a caffeine-based 
therapy, in which the therapy is not only based on drinking coffee or other caffeine-
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Chronische leverziekten zijn een grote last voor de gezondheidszorg; ze komen vrij 
vaak voor en gaan gepaard met ernstige morbiditeit die veel ziekenhuisopnames vereist. 
Er zijn verschillende oorzaken voor chronische leverziekten. De meest bekende zijn virale 
hepatitis en alcohol-geïnduceerde leverschade, maar ook obesitas leidt tot leverziekte 
door leververvetting (steatose). Ongeacht de oorzaak van de leverziekte, leidt het vaak 
tot verbindweefseling van de lever, fibrose, en het laatste stadium van deze leverziekte 
is levercirrose. 
De verbindweefseling van de lever ontstaat uit een wondgenezingsreactie. Door de 
schadelijke stimulus gaan de functionele levercellen (de hepatocyten) dood en er treedt 
een ontstekingsreactie op om de schade te beperken. Daarbij worden myofibroblasten 
(stellaatcellen, portale myofibroblasten) geactiveerd die littekenweefsel produceren. In 
de acute, kortdurende fase is dit een gunstige reactie, die ervoor zorgt dat een wondje 
weer dichtgaat en geneest. Echter, als er aanhoudende schade is, kan er een chronische 
wondgenezingsreactie ontstaan. Deze voortdurende ontstekingsreactie zorgt voor 
een aanhoudende stimulatie van myofibroblasten, terwijl er steeds meer hepatocyten 
doodgaan. Dit wordt de lever-paradox genoemd: in dezelfde omgeving gaan hepatocyten 
dood, maar de myofibroblasten delen en produceren volop littekenweefsel. 
Een belangrijke component van de chronische ontstekingsreactie is oxidatieve stress. 
Oxidatieve stress wordt gedefinieerd als een teveel aan zuurstofradicalen, en daardoor een 
verstoring van het normale evenwicht tussen pro- en antioxidanten. Zuurstofradicalen 
zijn onder andere waterstofperoxide en superoxide anionen. Deze kunnen ontstaan 
in fysiologische omstandigheden (bijvoorbeeld bij het normale celmetabolisme en het 
gebruik van zuurstof), maar ook in pathologische omstandigheden. In pathologische 
omstandigheden worden zuurstofradicalen geproduceerd door ontstekingscellen zoals 
macrofagen (Kupffer cellen), maar ook bij het doodgaan van hepatocyten of bij het 
metabolisme van alcohol of paracetamol komen zuurstofradicalen vrij.
Een cel is normaal uitgerust met een aantal antioxidantmechanismen. Deze zijn in 
staat om zuurstofradicalen te neutraliseren. Allereerst is er de familie van superoxide 
dimsutases (SODs), deze zetten superoxide anionen om in waterstofperoxide. Er zijn 
een aantal vormen van, koper-zink SOD (of CuZnSOD) bevindt zich in het cytoplasma 
van de cel en mangaan SOD (MnSOD) is gelokaliseerd in de mitochondriën van de cel. 
Waterstofperoxide wordt vervolgens weer omgezet in water en zuurstof door andere 










































Om de lever paradox te kunnen verklaren is onze veronderstelling dat er een 
aanpassingsvermogen is van de myofibroblasten (voornamelijk afkomstig van de 
stellaatcellen). Mogelijk dat dit een aanpassing betreft van de antioxidantstatus van de 
cellen, waardoor ze beter bestand zijn tegen schadelijke invloeden.
Het doel van dit proefschrift was om de mechanismen van stellaatcel activatie te 
onderzoeken. Hierbij hebben we ons met name gericht op de rol van oxidatieve stress en 
anti-oxidant mechanismen in deze cellen. Ons uiteindelijke doel was een bijdrage leveren 
aan een therapie specifiek gericht op de stellaatcel als veroorzaker van lever fibrose. 
In hoofdstuk 2 hebben we de rol van heme oxygenase-1 (HO-1) onderzocht in het 
ontstaan van fibrose. We hebben in een in vivo diermodel van cholestatische leverziekte, 
het galgangligatie (BDL: bile duct ligation) model, gekeken naar de expressie van HO-1. 
HO-1 kwam enkel tot expressie in macrofagen (ED-1 positieve cellen).
HO-1 is vervolgens kunstmatig tot overexpressie gebracht in stellaatcellen en 
in macrofagen. In macrofagen met een verhoogd niveau van HO-1 expressie waren 
de merkers verhoogd die geassocieerd zijn met het pro-inflammatoire M1 fenotype 
van macrofagen. De merkers geassocieerd met het M2 fenotype, geassocieerd met 
littekenvorming en weefsel remodellering, waren in expressieniveau gedaald na HO-1 
inductie. In stellaatcellen zorgde HO-1 inductie niet voor een verandering van het 
activatieniveau. 
Hieruit kunnen we concluderen dat HO-1 in staat is om het fenotype van de 
macrofagen te veranderen. Deze kunnen op hun beurt mogelijk weer andere cellen 
beïnvloeden, bijvoorbeeld myofibroblasten en stellaatcellen. Hier moet nog verder 
onderzoek naar gedaan worden. Het feit dat HO-1 zorgt voor een pro-inflammatoir 
fenotype van de macrofagen lijkt op het eerste gezicht ongunstig, omdat ontsteking vaak 
wordt gekoppeld aan meer schade en daardoor meer fibrose. Echter, wij veronderstellen 
dat een initiële inductie van ontsteking gunstig is, omdat het zorgt voor een snelle 
eliminatie van de schadelijke stimulus. Dit zal op de langere termijn minder activatie 
geven van de stellaatcellen en dus minder fibrose. Bovendien zal een vermindering van 
het aantal macrofagen met het M2 fenotype zorgen voor een minder pro-fibrotische 
omgeving.
In hoofdstuk 3 hebben we de beschermende mechanismen van geactiveerde 











































hebben we de anti-oxidantprofielen van stellaatcellen bekeken, en rustende stellaatcellen 
vergeleken met geactiveerde stellaatcellen. Hieruit bleek dat er een aantal verschillen 
waren tussen rustende en geactiveerde stellaatcellen. De niveaus van glutathione en 
glutathione peroxidase (GPx1) stegen wanneer de stellaatcellen actief werden, terwijl de 
expressieniveaus van catalase en MnSOD dramatisch daalden.
Daarna hebben we geactiveerde stellaatcellen blootgesteld aan waterstofperoxide en 
gekeken naar mechanismen van celdood: apoptose, de gereguleerde vorm van celdood, 
of necrose, de niet-gereguleerde vorm. Geactiveerde stellaatcellen zijn resistent tegen 
waterstofperoxide-geïnduceerde celdood. Echter, indien de intracellulaire glutathione 
concentratie wordt verlaagd, zorgt waterstofperoxide voor necrose van de stellaatcellen. 
Remming van de activiteit van GPx1 en catalase (tegelijk en separaat) zorgt echter voor 
waterstofperoxide-geïnduceerde apoptose. 
De inductie van glutathione en GPx1 zijn een duidelijk aanpassingsmechanisme van 
de actieve stellaatcellen, en vooral glutathione lijkt onmisbaar te zijn. GPx1 en catalase 
zijn beiden verantwoordelijk voor het neutraliseren van waterstofperoxide, en waar GPx1 
geïnduceerd wordt bij stellaatcelactivatie, gaat catalase omlaag. Het remmen van beiden 
enzymen leidt tot apoptose van de stellaatcellen na blootstelling aan waterstofperoxide. 
Blijkbaar zijn ze toch even belangrijk bij het neutraliseren van waterstofperoxide. Voor 
apoptose lijkt glutathione noodzakelijk, en waarschijnlijk komt dit door de bepalende rol 
die glutathione speelt in het handhaven van de redox status van de cel. 
De studie in hoofdstuk 3 toont een aanpassingsmechanisme van stellaatcellen die zij 
verwerven tijdens hun activatie. De verhoging van intracellulaire glutathione spiegels 
maakt de cellen meer resistent tegen necrose, hoewel ze het vermogen om in apoptose 
te gaan behouden. Dit kan een verklaring zijn voor het verschijnsel dat stellaatcellen in 
apoptose gaan tijdens resolutie van fibrose.
De afname van MnSOD expressie in geactiveerde stellaatcellen lijkt niet te passen 
in de hypothese dat de stellaatcellen zich aanpassen aan een vijandige pro-oxidant 
omgeving. Zuurstofradicalen die geproduceerd worden tijdens leverfibrose zijn o.a. 
waterstofperoxide, superoxide anionen en hydroxylradicalen. Blijkbaar zijn stellaatcellen 
aangepast om beter om te kunnen gaan met waterstofperoxide, hoewel hun verdediging 
tegen superoxide anionen zwak lijkt met een verlaagde expressie van MnSOD en een 











































In hoofdstuk 4 hebben we de rol van MnSOD in stellaatcellen verder onderzocht, en 
in het bijzonder hebben we gekeken naar de mogelijkheid van het terugdraaien van de 
activatie van stellaatcellen door de expressie van MnSOD te verhogen.
MnSOD is tot overexpressie gebracht met behulp van een adenovirale vector in 
stellaatcellen. Deze overexpressie leidde tot een verlaging van merkers die geassocieerd 
zijn met geactiveerde stellaatcellen, en een verhoging van de merker die geassocieerd 
is met rustende stellaatcellen. Naast de veranderingen in deze merkers, waren de 
stellaatcellen ook fenotypisch veranderd. Ze waren kleiner en het typische filament 
netwerk was veel minder uitgesproken in de cellen die meer MnSOD hadden. 
Een inductie van MnSOD zou een betere bescherming betekenen van de 
mitochondrieën tegen superoxiden. Dit lijkt in tegenspraak met de hypothese dat 
geactiveerde stellaatcellen beter beschermd zijn tegen oxidatieve stress, omdat deze 
cellen juist weinig MnSOD hebben. Er zijn een aantal mogelijke verklaringen voor deze 
tegenstelling.
Ten eerste is bekend dat stellaatcellen tijdens hun activatieproces omschakelen naar 
een ander metabolisme. Als rustende cellen hebben ze een ‘normaal’ metabolisme van 
oxidatieve fosforylering als onderdeel van de citroenzuurcyclus, waar zuurstof gebruikt 
wordt om uiteindelijk ATP (een zogeheten energiedrager) te produceren. Echter, als de 
stellaatcellen actief worden, verandert het metabolisme in aërobe glycolyse, waarbij 
glucose wordt afgebroken zonder dat daarna de citroenzuurcyclus volgt. Dit wordt ook 
gezien in kankercellen en dit wordt het Warburg effect genoemd. Een ander kenmerk van 
dit Warburg effect is dat het aantal mitochondriën niet zoals verwacht afneemt, omdat er 
geen oxidatieve fosforylering meer is, maar juist toeneemt. Het is bekend dat kankercellen 
op dit metabolisme overschakelen, omdat het weinig zuurstof vereist. Mogelijk is dit ook 
het geval in stellaatcellen die activatie ondergaan. De hoge metabole activiteit die hierbij 
vereist is kan mogelijk niet opgebracht worden door oxidatieve fosforylering. Een ander 
punt is dat glycolyse ook besparend is ten opzichte van oxidatieve fosforylering, want 
er zijn veel grondstoffen nodig om de 36 ATP moleculen per glucosemolecuul te maken 
in de oxidatieve fosforylering in plaats van de 4 ATP moleculen per glucosemolecuul 
in glycolyse. De overgebleven biomassa in de glycolyse kan gebruikt worden voor de 
synthese van andere materialen, bijvoorbeeld de productie van extracellulaire matrix. 
Als MnSOD wordt geïnduceerd, zoals in onze studie is gebeurd, zien we dat de cellen 
meer kenmerken van rustende stellaatcellen krijgen, mogelijk gaat dit gepaard of wordt 











































Een ander interessant concept, dat de verlaging van MnSOD kan verklaren, is de 
mogelijk redoxcontrole van de celcyclus. Eerdere studies in embryonale fibroblasten laten 
zien, dat een verlaging van MnSOD leidt tot een verhoging van het aantal superoxide 
anionen en minder waterstofperoxide, en dit geassocieerd is met deling van de cellen. 
Andersom was een verhoging van MnSOD geassocieerd met het verlaten van de 
celcyclus. Of dit ook in onze studieopzet werkt, zal verder onderzocht moeten worden.
Tot slot hebben we in hoofdstuk 5 een toepasbare manier van fibrogenese-remming 
onderzocht. Geactiveerde stellaatcellen en Kupffer cellen zijn geïncubeerd met caffeine 
en een metaboliet van caffeine: 1,7-dimethylxanthine (1,7-DMX). Met deze behandeling 
bleken stellaatcellen minder actief te worden: zowel de merkers van actieve stellaatcellen 
als de proliferatie verminderde. Het effect van caffeine en 1,7-DMX bleek onafhankelijk 
van elkaar aanwezig, maar werd versterkt als beide stoffen tegelijk aanwezig waren. Dit 
wijst erop dat er zowel directe als indirecte effecten zijn van caffeine. 
Caffeine wordt normaal gesproken gemetaboliseerd door een enzym in de hepatocyten 
(cytochrome P450 2E1: CYP2E1). Dit enzym is niet aanwezig in stellaatcellen en ook 
nauwelijks in Kupffer cellen. Aangezien er wel effecten zijn van caffeine op stellaatcellen, 
is er waarschijnlijk een direct effect van caffeine. Uit de literatuur is bekend dat caffeine 
ook kan werken als adenosine receptor antagonist (in lage dosis) en in hogere dosis kan 
werken als een fosfodiësterase-remmer (wat remming geeft van de ontstekingsreactie). 
Echter 1,7-DMX heeft ook een antifibrotisch effect op stellaatcellen, wat aangeeft dat 
caffeine ook een indirect effect heeft op stellaatcellen. 1,7-DMX is één van de metabolieten 
van caffeine, andere metabolieten theobromine en theofylline hebben ook een remmende 
werking op het fosfodiësterase systeem met als effect remming van de ontsteking.
Kupffer cellen (de macrofagen uit de lever) behandeld met caffeine en 1,7-DMX lieten 
een verminderde LPS-geïnduceerde productie van het inflammatoire cytokine (TNF-α) 
zien. Ook lieten hepatocyten die behandeld werden met 1,7-DMX een verlaagde iNOS 
productie zien (een maat voor ontsteking) na stimulatie met een pro-inflammatoire 
cytokine mix (IL-1β, interferon-γ en TNF-α). Dit geeft aan dat caffeine in de gehele lever 
kan zorgen voor een vermindering van de ontsteking. 
Concluderend heeft caffeine zowel directe als indirecte antifibrotische effecten, via 
remming van de stellaatcelactivatie en via remming van de ontsteking. De werking van 










































Hoofdstuk 6 beschrijft tot slot een samenvatting van het proefschrift met een 
bespiegeling over eventuele klinische toepassingen in de toekomst. In dit proefschrift 
is enkel onderzoek verricht met cellen, waardoor de klinische toepassing wellicht niet 
direct duidelijk is. Dit proefschrift laat zien dat er verschillende therapieën zijn die 
zowel gunstig zijn voor de hepatocyten als voor andere cellen van de lever (bijvoorbeeld 
de stellaatcellen en de Kupffer cellen), zoals HO-1 inductie, MnSOD inductie of een 
behandeling met caffeine. Deze therapieën, die verschillende effecten hebben, zijn het 






















































































Eindelijk is het zover… HET IS AF!
Het leek bij vlagen nooit af te komen, weer een mislukt experiment, weer een isolatie met 
weinig cellen... Maar uiteindelijk met veel hulp is het dan toch gelukt.
Als eerste ben ik daarvoor veel dank verschuldigd aan mijn promotor: Prof. Dr. A.J. 
Moshage. Beste Han, ongelooflijk hoe jij altijd er weer een positieve draai aan kan geven, 
als je niet fysiek aanwezig was dan wel via de mail. Als ik door de bomen het bos niet 
meer zag, keerde ik na een gesprek met jou weer vol moed en enthousiasme terug naar 
het lab. 
Dan mijn tweede promotor, Prof. Dr. K.N. Faber, beste Klaas Nico, hoe vaak heb ik bij jou 
om de deur gekeken of Han er was... Voor een groot gedeelte van mijn promotietraject 
was jij het eerste aanspreekpunt voor mij, altijd in om even door de microscoop te kijken 
naar rare kleuringen. Heel erg veel dank voor de discussies tijdens de labmeetings.
Bij dezen wil ik ook de leden van mijn leescommissie, Prof. Dr. H. Van Goor en Prof. Dr. 
Henning, erg bedanken voor het lezen van mijn proefschrift. También muchas gracias a 
Prof. Dr. M. Arrese por leer mi tesis!
Hoe kon ik als geneeskundestudent, die stiekum veel meer alpha is dan bèta, zo’n 
proefschrift bij elkaar pipetteren? Onmogelijk zonder de hulp van de analisten van de 
MDL... 
Allereest Manon, van leren pipetteren tot hulp bij de laatste experimenten, van hulp 
bij berekeningen tot hulp bij de isolaties.. Heel erg bedankt! Super dat je ook me bij 
het laatste onderdeel van dit traject wil bijstaan als paranimf! Tjasso, heel erg bedankt 
voor alle vroege koffiemomentjes, hulp bij de confocale microscoop en advies over 
vanalles en nog wat. Het is altijd gezellig om even een praatje met je te maken, vooral 
op vrijdagmiddag als er niemand anders lijkt te werken! Janette, heel erg bedankt voor 
je adviezen bij kleuringen en qPCR. Bojana, bedankt voor de leuke tijd die we samen 
hebben gehad, samen strijdend op het CDP tegen allerlei mislukte isolaties... Heel veel 











































Dan mijn collega-PhD studenten van de MDL, wat een tijd hebben we beleefd.. Esther, 
samen begonnen als studenten en nu zijn we allebei PhD studenten in het Moshage-
Faber lab. Met jou is het altijd lachen, van samen in het lab Floris pesten met te kleine 
handschoenen tot congresbezoeken in San Fransisco en niet te vergeten Veldhoven en 
Spier. Ook zal ik nooit ‘the morning after’ het Land van Belofte vergeten… Gelukkig 
hebben we de foto’s nog! Dank dat je voor mij een jurk aantrekt als paranimf zijnde! Mark, 
wat een moeilijke tijd heb je achter de rug, tijd om vooruit te kijken en verder te gaan! 
Heel veel succes hiermee! Golnar, ik vond het heel erg fijn dat jij mijn kamergenoot was 
in het begin van mijn PhD! Omdat Han er vaak niet was, moesten we ons met z’n tweeën 
redden, en jij hebt me heel veel geleerd! Succes met je Nederlandse doktercarrière! Floris, 
als collega MD/PhD bij de MDL hebben we elkaar niet veel gezien, telkens afgewisseld in 
de kliniek en op het lab. Dank voor je niet aflatende enthousiasme en veel succes met het 
afronden van alles! Jackey, it was really nice to have you in the lab for two years. Thank 
you for explaining some experiments to me and thanks for our nice discussions and 
talks. Goodluck finishing your thesis in China! Atta, although we had our disagreements 
(for example about throwing away or passing cells ..:)) you always made me smile with 
your singing and your creative ideas. Good luck with your career! Anouk, dank je wel 
voor je vrolijkheid op het lab! Veel succes met het afronden van je proefschrift en veel 
geluk met je gezinnetje! Shiva, thank you for our nice talks! Goodluck with your research 
and enjoy your cat!  Ali and Danial, new members of the lab, I wish you all the best 
with your projects and Dutch lives!
Oudleden van het MDL lab: Sandra, Martijn, Axel, Titia, Jannes, Rohina en Elise, dank 
voor de tijd dat we hebben samengewerkt!
Natuurlijk dank aan mijn studenten Marja Haakma-de Haan en Fernanada Braga 
Seganfredo voor hun inzet en gezelligheid! Thank you!
Dank aan mijn kamergenoten boven het lab, vaak een oase van rust: Nienke (succes met 
het afronden van je proefschrift en met je nieuwe baan!), Jan Freark (succes met je leven 
na de verdediging!), Weilin (dank je wel voor de nederlandse gesprekken!), Mathijs 











































Iedereen die werkt(e) bij kindergeneeskunde (aka LDS): Andrea, Aycha, Angelika, Bert, 
Renze, Henk, Niels, Danny, Dicky, Henk Jan, Gijs, Lydia, Hans, Marcella, Marije, Arne, 
Brenda, Vera, Nicoline, Karen, Carolien, Marleen, Gemma, Wytske, Margot, Maurien, 
Otto, Gerard, Trijnie, Theo, Uwe, Vincent, Tim, Janine, Dolf, Hilde en Gea.
Dank aan de werkgroep Junior Scientific Masterclass voor het honoreren van mijn MD/
PhD project en de voorafgaande cursussen, in het bijzonder Michiel Hooiveld, Hanneke 
Kluin-Nelemans, Joke van der Mark en Robert Porte.
Veel dank aan mijn lieve vrienden en vriendinnen, waar ik niet veel tijd voor heb gehad, 
maar waar ik toch altijd lekker mee kon ontspannen en leuke dingen doen. Dank je wel 
Elise (voor het samen sporten) en Gerard, Myrthe (voor weekendjes Delft en met zn 
drieën naar de sauna opwarmen), Joke (voor gezellig kletsen en de support), Charlotte 
en Lucas (voor de gezellige avonden weddingplannen, kan niet wachten...), Jan, Jasper 
en Esther (mijn mede MD/PhDers en borrelaars uit Leeuwarden, altijd veel plezier 
gehad met jullie op borrels waar dan ook georganiseerd!), Josephine (mijn buddy-MD/
PhD, tegelijk begonnen en tegelijk klaar! We did it!), Jop en Bas (dank voor alle KEI-2005 
reünieën), Judith en Kyrill (succes met het afronden van jullie boekjes!).
Dank aan mijn lieve familie, altijd was het onduidelijk waar ik me nu weer mee bezig 
hield, en was ik nou nog steeds niet afgestudeerd..? Eindelijk is het klaar, het onderzoek 
is af en volgende maand ben ik ook afgestudeerd..
Dank je wel lieve Opa en Oma Vincent, lieve Ans, Erik & Judith en Mathijs. Een betere 
bijna-schoonfamilie kan ik mij niet wensen.
Lieve Oma, Sisy en Ed, Boy, Hans en Daan, Roos en Fee, Judith en Arjen (+Noa) dank je 
wel dat jullie zo’n lieve familie voor me zijn! Vooral het kerstdiner in 2012 vond ik heel 
erg geslaagd!










































Lieve Maurits, Hilde, Anne, Joris, Jelle en Charlotte, wat is het leuk om jullie grote zus 
te zijn, altijd gezelligheid met spelletjesavonden. Ik zou heel graag willen dat we dat 
vasthouden nu ieder zijn eigen leventje opbouwt!
Lieve Papa en Nynke, heel erg bedankt voor al jullie steun. Ik geniet van alle discussies, 
inhoudelijk over het werk, maar ook over algemene dingen. Bij jullie kan ik altijd wat 
kwijt, en jullie helpen me vaak weer de goede kant uit. Nu dit allemaal klaar is hebben 
jullie een etentje verdiend!
Thomas, mijn allerliefste schat, beste vriend, steun en toeverlaat. Heel erg bedankt voor 
alle opbeurende gesprekken als ik er weer eens helemaal doorheen zat... Voordat ik hier 
aan begon, 5 jaar geleden, zei ik al dat het niet gemakkelijk zou worden, maar zoals alles 






















































































Marjolein Tiebosch werd op 29 juli 1987 geboren in Maastricht. Na het voltooien van haar 
gymnasium examen aan het Maartenscollege te Haren in 2005, werd zij middels loting 
toegelaten tot de opleiding Geneeskunde aan de Rijksuniversiteit Groningen.
Tijdens haar bachelor kwam ze reeds in aanraking met het onderzoek op het maag-, 
darm-, en leverziektenlaboratorium van Prof. Dr. A.J. Moshage en Prof. Dr. Faber.
Na op dit lab haar scriptie voor de studie Geneeskunde te hebben voltooid, begon ze 
aan haar eerste jaar co-schappen in het UMCG. Tijdens dit jaar werd zij aangenomen voor 
een MD/PhD-traject op het lab MDL, welke startte in mei 2010. Van mei 2011 tot mei 2012 
deed zij haar tweede jaar co-schappen in het Medisch Centrum te Leeuwarden. Hierna 
keerde zij terug naar het lab om haar MD/PhD traject af te ronden. Na het inleveren van 
het proefschrift aan de leescommissie in oktober 2013 begon zij aan haar semi-artsstage 
op de afdeling Longziekten en Tuberculose in het UMCG, met als verdiepingsstage 
Longoncologie. Dit rondt zij eind maart 2014 af, waarna ze dit proefschrift zal verdedigen 
in april 2014. 
